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Emerging technologies for liquid chromatography (LC) separations and mass 
spectrometry (MS) have dramatically improved the throughput of top-down proteomics, 
which has allowed the identification of thousands of intact proteoforms in complex 
biological samples. Many proteins have multiple intact proteoforms (i.e. variants with 
different post-translational modifications, PTMs) and these proteoforms often exhibit 
differing functions in biological processes. Therefore, it is important to establish an 
accurate and high-throughput top-down approach for the analysis of intact proteoforms. 
The focus of this dissertation is the development and application of novel high-throughput 
quantitative top-down proteomics techniques to characterize intact proteins in complex 
biological samples (e.g., serum autoantibody repertoire). 
We have developed a two-dimensional separation platform for high-throughput 
top-down MS analysis, which employs high-pH and low-pH RPLC-MS for top-down 
proteomics. The high-pH and low-pH 2D RPLC has been widely applied in bottom-up 
proteomics; however, it has not been applied to intact protein separation. Our results 
demonstrated that the proposed high-pH and low-pH RPLC separation format has good 
orthogonality for intact protein separation. We have used our 2D Ph RP/RPLC platform 
for PTM characterization of complex biological samples such as E. coli and human cell 
lysates. This ‘salt-free’ RPLC process overcomes the disadvantage of other 
chromatographic methods, which require complicated sample processing (i.e., buffer 
exchange, desalting) before MS analysis, and the two dimensions of separation could be 
easily coupled for online analysis.  
One of the drawbacks of the platform is that a large amount of starting material is 
xii 
 
required and the sample handling process between each dimension can introduce variations 
in the sample and can cause loss of sensitivity due to sample loss during the transfer, 
recovery, and desalting processes. Moreover, the off-line multidimensional separation 
techniques are often time consuming, labor intensive, and low-throughput. To improve the 
throughput and sensitivity of the offline approach, we developed an online 2D ultra-high-
pressure nano-LC system for high-pH and low-pH RPLC separation in top-down 
proteomics. The online 2DLC platform enabled the characterization of 2000+ intact 
proteoforms from  5 micro-grams of intact E. coli cell lysate, presenting a potential for 
deep proteome characterization in mass-limited samples using top-down proteomics.  
The human serum autoantibody repertoire is extremely complicated and 
autoantibody development is crucial to the function of the human immune system. We have 
applied top-down MS methods to characterize the serum autoantibody repertoire. We 
implemented a 1D UPLC-TDMS platform and achieved separation of a mixture of 12 
antibody Fabs with highly homologous sequences. Furthermore, we characterized 86 Fab 
related mass features, which represents the first top-down analysis of the complexity of the 
human autoantibody repertoire. Using top-down proteomics techniques, the PTMs of 
monoclonal antibodies can also be characterized; this information could give valuable 
insight into autoantibody function and human immunity. 
Antibody-antigen interaction is the fundamental reaction of immune system. The 
clear characterization of paratope/epitope of an immune complex can help the 
understanding of immune response and possibly the mechanisms of related diseases. To 
characterize the immune complexes, we coupled a low-temperature LC system with 
hydrogen/deuterium exchange mass spectrometry (HDX-MS), and applied it to 
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characterize the epitopes of the protective antigen. 
Overall, our results demonstrate the utility of top-down proteomics for the analysis 
of the serum autoantibody repertoire and application of HDX-MS on immune complex 
characterization. Top-down proteomics techniques hold great promise for the discovery of 
novel serum autoantibody biomarkers, as well as the promotion of our understanding of 
pathogenic autoimmune processes. 
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Chapter 1 Introduction 
1.1 Background 
The proteome, the complex system of proteins expressed by a cell,  is essential for 
the activity of complex biochemical processes. The study of the proteome provides 
complementary information to genomics and transcriptomics, which promotes the 
understanding of cellular functions and signaling pathways. During the transcription and 
translation processes that are used to synthesize proteins, any gene and protein processing 
event such as allelic variation (e.g. coding polymorphisms), alternative splicing, and post-
translational modification may vary protein structure (Figure 1-1). Different protein 
products can be produced from a single gene due to these pre- and post- 
transcriptional/translational processes which results in the large diversity of the proteome 
compared to the diversity of the genome . These protein variants were designated with the 
term “proteoform” in 2013 [1]. Different proteoforms of the same protein may have 
different abundances and functions in the cellular environment and may be active in the 
regulation of gene expression. Thus, understanding the abundance and function of a 
proteoform in a biological system is extremely important to study and understand the 







Figure 1-1. Central dogma of molecular biology. 
 
Proteomics is the large-scale study of proteins[2, 3]. Unlike the relatively constant 
genome in a biological system, the proteome is dynamic. This means that, even from a 
distinct set of genes, proteoform identity and abundance can vary in different cells; PTMs 
and of abundance can also change over the lifetime of the cell[4]. To study proteins, ligand 
binding assays such as antibody-based immunoassays (e.g. enzyme-linked immunosorbent 
assay, ELISA) and mass spectrometry-based methods have been the most commonly 
applied methods in the past decades. Antibody-based immunoassays require known 
antibodies against proteins of interest for affinity purification. These antibodies can be time 
consuming and labor intensive to produce and antibody-based immunoassays cannot reveal 
protein structural information. Traditionally, mass spectrometry-based proteomics have 
utilized two-dimensional polyacrylamide gel electrophoresis (2D PAGE) for front end 
protein separation prior to mass spectrometry analysis. After the protein mixture is 
separated on a PAGE gel, the protein bands of interest are isolated, subjected to sample 
preparation (e.g. in-gel enzymatic digestion), and detected using a mass spectrometer. 
However, 2D PAGE is time consuming and low throughput.  
The use of high-resolution front-end separation techniques such as reversed phase 
3 
 
liquid chromatography (RPLC) and capillary electrophoresis (CE) has emerged as an 
alternative to 2D PAGE for protein separation. Using these online separation techniques, 
thousands of proteins can be detected from a single sample using mass spectrometry. 
Additionally, the advancement of high-end mass spectrometry instruments (e.g. FTICR, 
Orbitrap, Time-Of-Flight mass analyzers, and etc.) has enabled the fast and accurate 
detection of large biological molecules (e.g. peptides and proteins). Through the 
application of online separation techniques, predominantly LC, coupled with mass 
spectrometric detection, large scale, routine, and high-throughput analysis of proteins is 
becoming feasible and reliable.  
1.2 High-throughput proteomics 
 There are about 20,000 protein-coding genes in the human genome [5, 6], and an 
estimated 1,000,000 proteoforms from one cell type in the human proteome. Most of these 
different proteoforms are responsible for unique biological processes and control the 
function or misfunction of the human body[6]. The comparatively large diversity in the 
human proteome stems from sources such as alternative splicing, PTMs, etc. However, we 
have very limited knowledge on the function of proteoforms in health and disease. 
Understanding the identity, abundance, and function of important proteoforms will provide 
useful information for disease diagnosis and treatment. Considering the large size of the 
human proteome, high-throughput techniques are needed to map as many human 
proteoforms as possible. 
The aim of high-throughput proteomics is deeper proteome coverage with 
decreased analysis time[7]. There are three main approaches to high-throughput mass 
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spectrometry-based proteomics: bottom-up, middle-down, and top-down proteomics 
(Figure 1-2).  
 
 
Figure 1-2. Scheme of bottom-up and top-down proteomics. 
 
In bottom-up proteomics, proteins are normally enzymatically digested (e.g. tryptic 
digestion) and analyzed by LC-MS techniques. Full MS scans can be used for peptide 
quantification and tandem mass spectrometry is utilized for peptide sequencing and 
identification. In top-down proteomics, intact proteins are directly separated using LC and 
detected using high-resolution mass spectrometry. In middle-down proteomics, proteins 
undergo limited proteolysis to produce relatively large peptides (i.e. 3 – 9 kDa), the 
resulting peptides are then separated and detected by LC-MS/MS[8].  
Bottom-up methods have been widely applied to proteomics studies and are capable 
of identifying thousands of peptides in a single analysis. Bottom-up proteomics is robust 
and sensitive, but it cannot provide accurate information on the combinatorial modification 
patterns of proteoforms (Figure 1-3). Top-down proteomics analyzes intact proteins and 
allows for the identification of PTM patterns, sequence variations, etc., providing a 
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complete description of the primary structure of the protein and its modifications. Middle-
down proteomics is a popular method because it preserves combinatorial modification 
patterns on proteoforms and can approach the sensitivity of bottom-up proteomics. Middle-
down proteomics is extensively applied for histone proteomics[9, 10]. 
 
 
Figure 1-3. Bottom-up proteomics results in loss of proteoform information. 
 
The biological functions of different proteoforms largely rely on the abundance and 
PTM of the proteoform (e.g. histone code). Bottom-up proteomics is more robust for 
protein identification; however, the proteoform information in terms of PTM location, 
pattern, and abundance will be lost. High-throughput top-down proteomics has become 
more accessible thanks to the advancement of online separation/offline fractionation 
workflows, high-resolution MS instrumentation, and fragmentation techniques for large 
gas phase molecules. 
Top-down proteomics analyzes intact proteoforms which preserves the primary 
structure of different proteoforms and information of PTMs. Top-down proteomics 
provides a promising tool for the identification of novel proteoforms, deeper understanding 
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of protein sequences, and the quantification of functional PTMs[11, 12]. Top-down 
proteomics was previously limited to the analysis of pure intact proteins and targeted 
analysis of proteins of interest in its early development[13-15]. Over the past 5 to 10 years, 
top-down proteomics has been rapidly improved thanks to the fast development of 
separation techniques and high resolution mass spectrometers[12]. Now, global profiling 
of proteomes using top-down proteomics is feasible, enabling the identification and 




Figure 1-4. Typical workflow of a high-throughput top-down proteomics study. 
 
Typically, a high-throughput top-down proteomics study starts from protein 
extraction (i.e., sample preparation), followed by protein separation, and MS detection[22]. 
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Top-down proteomics is developing quickly; however, there are still significant challenges 
posed by the complexity of protein samples, e.g. the wide dynamic range of proteoforms 
in a biological sample and the large size of intact proteins[23]. The high degree of 
complexity requires optimization or customization for each step of top-down analysis.  
Different sample preparation strategies can be utilized based on the characteristics 
of protein samples to be analyzed. In the case of physiological samples that are not 
compatible with separation and MS detection, buffer exchange of the proteins can be 
performed. Traditionally, filter-aided sample preparation (FASP) has been applied where 
protein samples are centrifuged through a membrane of certain pore size. This method 
provides an easy process for protein sample buffer exchange and desalting. For samples 
that contain proteins of interest at low abundance, enrichment of selected proteins can be 
performed. For example, immunoprecipitation and immobilized metal affinity 
chromatography (IMAC) can be used to enrich phosphoproteins.  
The throughput of the top-down proteomics workflow has also been improved with 
the advancement of high-resolution separation techniques, high-resolution MS instruments 
with fast scan rate, and accessible bioinformatics tools.   
1.2.1 Separation techniques for top-down proteomics 
One of the major goals of global profiling of proteomes using top-down proteomics 
is to identify and quantify as many proteoforms as possible from biological samples. The 
number of identified proteoforms directly correlates with the separation power of 
separation techniques, and MS and MS/MS scan quantity and quality. Separation 
techniques with higher resolution reduce the ionization competition from co-eluted 
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analytes because the proteoforms can be concentrated into a sharper elution peaks; this 
results in higher sensitivity of MS detection.  A variety of separation methods that separate 
proteins based on different mechanisms (e.g. size, charge, polarity) have been evaluated 
for protein separation for top-down proteomics. Separation techniques that have been 
applied to the separation of intact proteins include reversed phase liquid chromatography 
(RPLC), hydrophilic interaction chromatography (HILIC), size exclusion chromatography 
(SEC), hydrophobic interaction chromatography (HIC), and ion exchange chromatography 
(IEC)[24, 25]. Electrophoresis-based methods such as gel-eluted liquid fraction entrapment 
electrophoresis (GELFrEE)[26] and capillary electrophoresis (CE) have also been applied 
to the separation of intact proteins[27]. These various separation techniques provide a pool 
of tools for the separation of intact proteins for MS analysis.  
RPLC is the most prevalent approach for studying complex intact protein 
samples[7, 11, 28-30]. CE has also been applied as a complementary separation technique 
to RPLC for the separation of peptides and proteins in proteomics studies. While CE 
provides higher theoretical plate numbers and more efficient separation, the application of 
CE has been limited due to the characteristics of the method. For example, as CE is a nano-
scale sample separation technique, the limited sample loading amount results in the 
inability to detect low abundant proteins. In addition, compared to LC based techniques, 
the reproducibility of CE is relatively poor, making it hard to apply to routine analysis[27, 
31, 32]. Given the challenges of CE, top-down proteomics with LC separation techniques 
are still the most applicable and feasible approaches currently available. Various 
approaches have been developed to improve RPLC separation power [33-35] including the 
utilization of ultra-high pressure LC systems with longer columns [36] or smaller column 
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particle sizes. These advancements serve to improve the peak capacity of the 1D RPLC 
separation [37].  
Since single dimensional separation techniques separate proteins based on a single 
physicochemical property, they can never resolve the whole proteome. Multi-dimensional 
separation platforms have emerged to separate proteins based on multiple physicochemical 
properties. Different separation techniques can be coupled together either online or offline 
(i.e., pre-fractionation) to extend the separation power of front-end separation for top-down 
proteomics. Multidimensional separation can result in more identification of proteins and 
a deeper and more comprehensive understanding of proteoforms. In order to maximize the 
utilization of the separation window, the different dimensions of multidimensional 
separation techniques need to be orthogonal, meaning that the same protein will have 
different elution behaviors in the different dimensions (Figure 1-5A). If the separation 
mechanism of the first dimension is the same or similar with the second-dimension 
separation, the same protein will be eluted out at a similar retention time in the first- and 
second-dimension separations, resulting an inefficient usage of whole separation window 
(Figure 1-5B). 
 
Figure 1-5. Orthogonality demonstration. 
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In the past decades, various multi-dimension techniques have been developed for 
top-down proteomics. In 2010, Tian and his coworkers developed weak cation exchange 
chromatography and hydrophilic interaction chromatography (WCX/HILIC) coupled to 
RPLC for histone studies[33]. In 2011, the Kelleher group reported a four-dimensional 
separation platform that coupled isoelectric focusing, multiplex GELFrEE, and 
nanocapillary LC-MS. This platform demonstrated greater than 20-fold increase in both 
separation power and proteome coverage[38]. In 2014 and 2015, the Ge group developed 
a method that coupled HIC to RPLC and three-dimensional separation using IEC, HIC, and 
RPLC for intact protein analysis [21, 39]. Traditionally, the multidimensional separation 
platforms involve sample processing between different dimensions (e.g., desalting, 
concentrating), which can be time consuming and labor intensive. More importantly, 
offline fractionation requires a large amount of starting materials which limits the 
application of multi-dimensional separation for top-down proteomics in some situations. 
Although, the online 2DLC system has been reported for histone analysis [33], no 
automated online multi-dimensional separation platform has been reported for global 
profiling of proteomes. Multi-dimensional separation for top-down proteomics has been 
effective; however, the instrumentation of the multi-dimensional separation system will 
need to be further improved for more robust and high-throughput analysis of intact protein 
samples. 
1.2.2 The development of mass spectrometry for top-down proteomics  
The very early top-down MS characterization of intact protein was performed on 
quadrupole-based instruments. Compared to modern MS instrument, quadrupole-based 
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instruments are simpler but the mass resolving power is poor, which leads to inaccurate 
mass measurement. With the invention and development of high-resolution mass 
analyzers, the benefits of top-down proteomics started to shine. Fourier-transform ion 
cyclotron resonance (FTICR) mass analyzers and Orbitrap mass analyzers are currently 
more commonly used for top-down MS analysis. Other types of instruments, such as linear 
ion traps, time-of-flight (ToF) mass analyzers, can also be applied to analyze intact 
proteins. Compared to FTMS, ToF mass analyzer can detect intact proteins with very high 
m/z, making it preferable for large protein complex detection. However, the FTMS 
instruments provide excellent sensitivity and high mass accuracy, allowing better 
characterization of proteoforms for top-down proteomics. The improved mass accuracy 
and high resolving power of modern MS instruments enables the detection of monoisotopic 
masses of intact proteins. In addition, the high-resolution mass detection can also resolve 
overlapped fragment ions with similar masses, resulting in more confident assignment of 
fragment ions[40]. 
One of the aims of top-down proteomics is the deep characterization of proteoforms 
with more accurate primary structure characterization, PTM localization, and relative 
quantification. Ion dissociation techniques have been development to increase the internal 
energy of analyte ions to the dissociation threshold to generate fragment ions. The fragment 
ions can be further analyzed by tandem mass spectrometry (i.e., MS/MS) and used to 
characterize the proteins. Currently, collision-based dissociation methods are still 
commonly used for protein identification. However, to increase the sequence coverage and 
better characterize proteoforms (e.g. localization of PTMs), different dissociation 
















Figure 1-6. Peptide backbone fragmentation. 
 
Different dissociation techniques fragment ions using different mechanisms, such 
as gas-phase collisions (CID, HCD), surface induced collisions (SID), photodissociation 
(UVPD), electron capture/transfer dissociation (ECD/ETD), etc. The peptide backbone in 
a protein can be cleaved at different sites depending on the type of dissociation technique 
used (Figure 1-6). b- and y- ions can be produced by “slow-heating” techniques, such as 
CID and HCD, c- and z- ions can be produced by ECD, ETD, UVPD, etc., and  a- and x- 
ions are normally generated with electron-mediated techniques for anionic analytes, such 
as electron detachment dissociation (EDD), negative electron transfer dissociation (nETD), 
etc [41]. b- and y- ions, c- and z- ions are the most commonly used for characterization of 
proteins in top-down proteomics. 
Different dissociation techniques can be utilized to address different experimental 
applications. For example, HCD is generally used with Orbitrap type instruments for high 
throughput protein identification. UVPD can be applied to sequence intact monoclonal 
antibodies[42]. ETD can be beneficial to PTM analysis, especially to glycoproteomics, 
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since the glycans can be easily dissociated with collision-based dissociation 
techniques[43].  
1.3 Serum autoantibody proteomics 
The human immune system protects human health against disease pathogens 
mainly through the adaptive immune system that is reliant on the diversification of the 
antibody repertoire in response to antigenic determinants (antigens)[44]. When the B cell 
antigen receptor (BCR) on the cell membrane recognizes a specific antigen, the B cell 
undergoes a series of somatic gene rearrangement events to produce a specific antibody 
that can bind to the antigen. This antibody can prevent future attack from the same disease 
pathogen[44, 45]. However, the immune system can be overactive and result in 
autoimmune diseases such as Sjögren’s syndrome (SS) and systemic lupus erythematosus 
(SLE). Autoimmune diseases occur when the immune system recognizes a self-antigen and 
generates an autoantibody against the autoantigen which will attack healthy tissue, organs, 
etc[46, 47].  
To understand the mechanisms of autoimmune diseases, current studies focus on 
autoantigens and their autoepitopes[46, 48-51]. However, such research provides no 
information on molecular characteristics, clonality, variable gene usage, or mutational 
status of the autoantibodies[45, 46]. Mass spectrometry-based proteomics techniques have 
been used for the detection and characterization of serum monoclonal antibodies. Several 
bottom-up and middle-down approaches have been developed to identify autoantibodies in 
serum[52-54]. However, there are inherent challenges with bottom-up approaches for the 
analysis of the highly diverse serum antibody repertoire. In order to produce an 
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autoantibody repertoire of high diversity, the VDJ recombination process produces an 
astronomical number of antibody sequences (Figure 1-7). A finite set of variable (V), 
diversity (D), and joining (J) germline gene segments will arrange together tandemly, with 
the random addition or deletion of N-nucleotides, to make a unique antibody sequence. The 
unique process of VDJ recombination diversifies the antibody repertoire, however, the 
majority of the antibody sequences share common primary sequences from common VDJ 
and C (constant) gene families. This recombination results in a pool of peptides with both 
shared and non-shared sequences. Even assuming 100% sequence coverage (which is 
nearly impossible to generate with bottom-up approaches), bottom-up MS is unable to 
identify the precise coordination of individual sequences for each IgG. Top-down 
proteomics uses high resolution MS for accurate mass detection distinguishing different 
antibodies. It also allows for post-translational modification mapping and preserves the 
light chain and heavy chain pairing information. The advantages of top-down proteomics 
make it a promising tool for comprehensive antibody proteomics. 
 
Figure 1-7. The VDJ recombination diversifying the antibody repertoire.  
V: variable gene segment; D: diversity gene segment; J: joining gene segment; N: non-




1.4 Dissertation synopsis 
This dissertation presents the development and application of high-throughput top-
down proteomics techniques to enable the deeper understanding of proteomes and related 
biochemical processes. A 1D high-performance liquid chromatography platform using a 
long capillary RPLC column was developed for complex intact protein sample analysis. 
The platform achieved a high peak capacity for intact proteome separation. To further 
improve the throughput, an online comprehensive 2DLC platform couples high-pH RPLC 
and low-pH RPLC for top-down proteomics (Chapter 2). The high-pH and low-pH 2D 
RPLC platform has previously been applied in bottom-up proteomics. This platform has 
good orthogonality for peptide separation, utilizes simple sample handling techniques, and 
‘salt’-free, MS friendly buffers. However, it has never been applied to intact protein 
separation. We evaluated the 2D pH RP/RPLC platform and observed orthogonality for 
intact protein separation. The 2DLC platform enables the deep identification of proteoform 
PTMs due to increased sensitivity. The 2DLC platform was further developed into an 
online automated system utilizing nano flow LC for both dimensions (Chapter 3). The 
automated online 2DLC system does not require sample handling between the two 
dimensions; as a result, less sample loss and artificial modifications occur during the 
experiment. More importantly, 100 times less starting material was needed (i.e., 5 μg vs. 
500 μg), to achieve similar performance to the offline 2DLC platform, which equates to a 
100-fold increase in sensitivity. 
Understanding the human autoantibody repertoire and immune complex is essential 
to explore the mechanism of autoimmune diseases for disease management and treatment. 
We applied high-throughput top-down proteomics to the analysis of antigen-binding 
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fragments from serum autoantibody repertoire (Chapter 4). To our knowledge, this work 
is the first, to date of publication, top-down MS analysis of the human serum autoantibody 
pool and has enabled the classification of light chains and heavy chains. Our top-down 
approach gives us a ‘bird’s-eye’ view of the complexity of human serum autoantibodies. 
Further, we optimized and evaluated a low-temperature LC system coupled with HDX-MS 




Chapter 2 Two-dimensional separation using high-pH and low-pH 
reversed phase liquid chromatography for top-down proteomics 
2.1 Abstract 
Advancements in chromatographic separation are critical to in-depth top-down 
proteomics of complex intact protein samples. Reversed-phase liquid chromatography is 
the most prevalent technique for top-down proteomics. However, in cases of high 
complexities and large dynamic ranges, 1D-RPLC may not provide sufficient coverage of 
the proteome. To address these challenges, orthogonal separation techniques are often 
combined to improve the coverage and the dynamic range of detection. In this study, a 
“salt-free” high-pH RPLC was evaluated as an orthogonal dimension of separation to 
conventional low-pH RPLC with top-down MS.  The RPLC separations with low-pH 
conditions (pH=2) and high-pH conditions (pH=10) were compared to confirm the good 
orthogonality between high-pH and low-pH RPLC’s. The offline 2D RPLC-RPLC-MS/MS 
analyses of intact E. coli samples were evaluated for the improvement of intact protein 
identifications as well as intact proteoform characterizations. Compared to the 163 proteins 
and 328 proteoforms identified using a 1D RPLC-MS approach, 365 proteins and 886 
proteoforms were identified using the 2D RPLC-RPLC top-down MS approach. Our 
results demonstrate that the 2D RPLC-RPLC top-down approach holds great potential for 
in-depth top-down proteomics studies by utilizing the high resolving power of RPLC 
separations and by using mass spectrometry compatible buffers for easy sample handling 




Post-translational modifications (e.g., phosphorylation, glycosylation, acetylation, 
etc.) and other cellular biochemical processes often result in various modified proteoforms 
of a single protein, which are recognized as important functional molecular signatures for 
disease diagnosis and potential drug targets[38]. Several mass spectrometry (MS) based 
proteomics approaches are currently available: bottom-up proteomics, middle-down 
proteomics, and top-down proteomics[7]. Bottom-up proteomics offers high sensitivity, 
high throughput, and good sequence coverage for studying complex protein samples[7, 
55].  Middle-down proteomics refers to the partial cleavage of intact proteins into a few 
large fragments prior to LC-MS/MS analysis[56]. However, both techniques often result 
in the loss of information for different proteoforms. In top-down proteomics, intact protein 
samples are directly analyzed using MS without any pre-treatment. Compared to bottom-
up proteomics and middle-down proteomics, top-down proteomics has the advantages of 
the preservation of intact proteoforms[57]. Therefore, top-down proteomics is being 
increasingly utilized for proteome studies. Additionally, in recent years, high-speed and 
high-resolution MS instrument development (i.e., orbitrap and FTICR MS) has greatly 
advanced the field of top-down proteomics[58-60].   
One of the main challenges of top-down proteomics is the lack of high-resolution 
separation techniques for complex protein samples[39, 61]. Reversed phase liquid 
chromatography (RPLC) coupled online with MS is the most prevalent approach for 
studying complex intact protein samples in top-down proteomics[7, 11, 28-30]. Various 
approaches have been developed to improve the separation power of the RPLC 
analysis[33-35]. One of the major efforts is to utilize ultra-high pressure LC systems with 
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longer columns[36] or smaller particle sizes, improving the peak capacity of the 1D RPLC 
separation[37]. However, due to extreme complexities, limited sample loading amounts, 
and large dynamic ranges of intact protein samples, 1D RPLC alone may not provide 
sufficient proteome coverage for top-down proteomics.  Capillary electrophoresis (CE) has 
also been applied as a complementary separation technique to RPLC for the separation of 
peptides and proteins in proteomics studies. However, the application of CE has been 
limited for several reasons. Low concentration and ionic strength of the analytes is required 
to minimize peak broadening and peak distortion. Limited sample loading amounts and 
relatively poor reproducibility of CE have also limited its wide application[27, 31, 32]. In 
addition, confident intact protein and proteoform characterizations often require good 
quality fragmentation peaks by averaging several MS/MS scans, and this is a rate limiting 
step for both 1D RPLC analysis and CE based separations.  
To address these challenges, various orthogonal separation techniques (i.e., 2D LC) 
are often combined to improve proteome coverage and increase the dynamic range of 
detection[62, 63]. Different separation methods have been evaluated and optimized as 
complimentary separation techniques to RPLC, including hydrophilic interaction 
chromatography (HILIC), size exclusion chromatography (SEC), hydrophobic interaction 
chromatography (HIC), and ion exchange chromatography (IEC), etc. [24, 25]. 
Electrophoresis-based separation techniques, such as gel-eluted liquid fraction entrapment 
electrophoresis (GELFrEE)[26], and capillary zone electrophoresis (CZE) [27] have also 
been used. HILIC has been successfully applied to histone proteoform analysis[64, 65], but 
it is not widely applicable due to poor solubility of many proteins in organic loading 
buffers. SEC separates proteins based on the sizes of the proteins which provides a 
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complementary mechanism to RPLC and is useful for the identification of large proteins. 
However, SEC often has low peak capacity for protein separation[66, 67].  HIC is a 
technique that separates proteins based on the hydrophobicity with high resolution. It also 
provides complementary selectivity to RPLC[20, 68]. However, HIC provides inadequate 
protein retention and is often limited by the concentrations of salts in the mobile phase. 
These problems of HIC were overcome by several studies. Ge’s group developed the online 
HIC-MS platform with the MS-compatible  salt ammonium tartrate[39], and more recently,  
introduced a novel hydrophobic HIC packing material that can retain proteins with MS-
compatible salts such as ammonium acetate[20]. IEC is another commonly applied pre-
fractionation approach in top-down proteomics. It offers good separation power and is 
highly orthogonal to the RPLC separation.  However, IEC buffers contain high 
concentrations of non-volatile salts that are incompatible with MS, and additional desalting 
steps are always required prior to MS analysis[69]. Therefore, there is a general need to 
develop complementary separation approaches to couple with RPLC-MS for top-down 
analysis.  
Using high-pH RPLC as the first-dimension of separation offers the possibility of 
retaining the high resolution of RPLC and bringing orthogonality to the second dimension 
of the RPLC separation[70, 71]. It has been widely applied to bottom-up MS approaches 
due to the good or even better performance compared to current state-of-the-art strong 
cation exchange (SCX)-RPLC separation. In addition, the MS compatible mobile phases 
simplify the sample processing because no desalting step is required for the secondary 
dimension of the separation. However, this approach has not been applied to intact protein 
separation. In this study, we evaluate the high-pH and low-pH RPLC’s for intact protein 
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separation using standard proteins and E. coli intact proteins. The optimized 2D separation 
platform was further applied to the separation and the identification of E. coli intact 
proteins and proteoforms. Our results demonstrate that the proposed platform provides high 
resolving power for both RPLC separations, good orthogonality between the two 
dimensions, and easy sample handling with mass spectrometry compatible buffers. 
2.3 Material and methods  
2.3.1  Materials and reagents 
LC/MS CHROMASOLV® grade isopropanol (IPA), acetonitrile (ACN), and water 
were purchased from Sigma-Aldrich (St. Louis, MO). Analytical reagent (AR) grade 
ammonium formate (AF) and acetic acid (HAc) were also procured from Sigma-Aldrich. 
Pierce™ Trifluoroacetic Acid (TFA), formic acid (FA), and the Pierce™ BCA Protein 
Assay Kit were obtained from Thermo Scientific (Hanover Park, IL). Three standard 
proteins, α-Casein from bovine milk, carbonic anhydrase from bovine erythrocytes, and 
cytochrome c from bovine heart were obtained from Sigma-Aldrich. The packing materials 
for packing C5 (Jupiter particles, 5 µm diameter, 300 Å pore size) and C18 (Jupiter 
particles, 5 µm diameter, 300 Å pore size) columns were purchased from Phenomenex 
(Torrance, CA). 
2.3.2  Sample preparation 
Standard protein solutions (CAS, α-Casein from bovine milk; CAH, carbonic 
anhydrase from bovine erythrocytes; Cyt, cytochrome c from bovine heart) were prepared 
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by dissolving the lyophilized proteins into the HPLC mobile phase A (0.1% TFA in water 
for low-pH RPLC, 20 mM AF in water for high-pH RPLC) to a final concentration of 1.0 
mg/mL. Intact soluble E. coli cell lysate proteins were obtained from the BL21 strain grown 
in house and by a bead-beating approach described in the literature[72]. Aliquots of protein 
solutions were stored at -80 oC until further use. 
2.3.3 1st dimension RPLC separation and fractionation 
The first-dimension separation was performed on a Thermo Accela HPLC system 
(Thermo Scientific, Hanover Park, IL). An XBridge® Protein BEH C4 column (300 Å, 3.5 
μm, 2.1 mm × 250 mm) from Waters, Inc. (Milford, MA) was used. For high-pH (pH=10) 
1st dimension fractionation, the mobile phase A (MPA)was 20 mM ammonium formate in 
water and the mobile phase B (MPB) was 20 mM ammonium formate in acetonitrile. The 
mobile phases were adjusted to pH 10. For low-pH (pH=2) 1st dimension fractionation, the 
mobile phase A was 0.1 % TFA in water and the mobile phase B was 0.1 % TFA in ACN. 
For both approaches, the LC flow rate was 150 μL/min, and the UV absorbance detection 
wavelength was set at 280 nm. Five hundred micrograms of E. coli intact proteins or 50 μg 
of the three standard proteins were loaded onto the column. For direct comparison between 
the high-pH 1st dimension RPLC separation and the low-pH 1st dimension RPLC 
separation, the same gradient was applied, and the same column was used. The LC method 
was set at 5 minutes for sample loading followed by a 60-minute separation gradient from 
10% to 70% of MPB. The column was regenerated by running 90% of MPB over 10 
minutes and equilibrated to 97% of MPA for the next run. Twenty-four fractions were 
collected by a fraction collector. Each fraction was vacuum dried and stored at -20 oC. 
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Right before the analysis using second-dimension RPLC, each fraction was reconstituted 
by adding 100 μL of MPA for the second-dimension RPLC (0.01 % TFA, 0.585% HAc, 
2.5% IPA, and 5% ACN in water). The protein content and concentration of each fraction 
were evaluated by SDS-PAGE gel and BCA Protein Assay Kit. 
2.3.4 2nd dimension top-down RPLC-MS/MS analysis 
An in-house packed nano-flow capillary C5 column (5 μm, 75μm × 75 cm) was 
used on a modified Thermo Accela HPLC system. The RPLC conditions were similar to 
those previously reported[73, 74]. The mobile phase A was 0.01% TFA, 0.585% HAc, 
2.5% IPA and 5% ACN in water, and the mobile phase B was 0.01% TFA, 0.585% HAc, 
45% IPA and 45% ACN in water. 25 μL of each reconstituted fraction (i.e., ¼ of each 
fraction) was loaded on an SPE column for sample trapping and cleaning. A 280-minute 
gradient from 10% A to 80% B at a flow rate of about 400 nL/min was applied for the 
separation and the column was regenerated by running 90% of MPB for 10 minutes and 
equilibrated to 97% of MPA. The second-dimension RPLC was coupled directly to an LTQ 
Orbitrap Velos Pro mass spectrometer for MS analysis. Eluents from the second-dimension 
RPLC were electro sprayed from a custom designed nano-ESI source into an LTQ Orbitrap 
Velos Pro mass spectrometer (ThermoFisher Scientific, Bremen, Germany). The 
electrospray voltage was set to 2.6 kV and the heated inlet capillary temperature was 
optimized to 300 °C. MS data were collected at the resolving power setting of 100 000 (at 
m/z 400) with two micro scans. Data-dependent MS/MS acquisition was performed by 
selecting the top five most abundant precursor ions in the MS scan with an isolation width 
of 3.0 and fragmenting them using collision induced dissociation (CID) with a normalized 
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energy of 35%. The MS/MS data were obtained at a resolving power setting of 60 000 (at 
m/z 400) with one micro scan. Ions with less than 4 charges were rejected for the selection 
of MS/MS scans. The maximum injection time for a full mass scan and MS/MS scan were 
set to 1000 ms. and 500 ms., respectively. The AGC target was set as 1 × 106 for full mass 
scans, and 5× 105 for MS/MS scans. All the data were collected with Xcalibur 3.0 software 
(Thermo Fisher Scientific, Bremen, Germany). 
The E.coli intact proteins were also analyzed by a single-dimensional RPLC-
MS/MS (1D RPLC) to compare with the 2D RPLC-RPLC-MS/MS platform. The exact 
same conditions for LC and MS as the 2nd dimension top-down RPLC-MS/MS analysis 
were applied. 
2.3.5  Bottom-up LC-MS/MS analysis of fractions from 1st dimension RPLC 
The fractions from the first-dimension RPLC separation were tryptic digested and 
analyzed by the bottom-up approach for the evaluation of orthogonality between the low-
pH RPLC and high-pH RPLC. Briefly, the vacuum dried fractions were reconstituted in 25 
mM ammonium bicarbonate (ABC) and 6 M urea. Two hundred mM dithiothreitol (DTT) 
was used to reduce the disulfide bonds. Two hundred mM iodoacetamide (IAA) was used 
to protect the thiol groups from re-forming disulfide bonds. Trypsin was added to fractions 
with a protein to enzyme ratio of 50:1 and the digestion was performed overnight at 37 oC. 
The digested fractions were desalted and loaded onto an in-house packed C18 column (5 
μm, 75μm × 15 cm) for the bottom-up study. The mobile phases were 0.1% formic acid in 
water (MPA) and 0.1% formic acid in ACN (MPB). The gradient was from 3% MPB to 
35% MPB over 40 minutes following a 15-minute sample loading step. The column was 
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regenerated with 90% MPB for 10 minutes and equilibrated to 3% MPB for 30 minutes.  
2.3.6  Protein and proteoform identification 
In bottom-up experiments, peptides were identified using MSGF+[75, 76] to search 
the mass spectra from the LC-MS/MS analysis against the annotated E coli. database and 
its decoy database. Peptide identifications were filtered using an MS-GF cut-off value of 
1x10-10 (i.e., the calculated FDR<1% at the unique peptide level). The intact protein 
MS/MS data were subjected to data analysis and protein identification using MS-Align+ 
(http://bix.ucsd.edu/projects/msalign/)[77] with the following search parameters: minimal 
precursor mass = 2500 Da; minimal fragment peaks per scan =10; maximum number of 
modifications = 2; fragment mass error tolerance = 15 ppm. MS-Align+ reported only the 
PrSM with the best E-value for each spectrum. LC-MS/MS data were searched against the 
annotated E coli. database. The false discovery rate (FDR) for protein/spectrum matches 
was estimated by searching top-down spectra against the human Uniprot database. A final 
E-value cutoff of 2x10-4[75] was used to achieve an FDR of 1%. All of the identified 
proteins and proteoforms were further manually evaluated. 
2.4 Results and discussion 
2.4.1  Evaluation of orthogonality between high-pH RPLC and low-pH RPLC 
We first evaluated the orthogonality between high-pH RPLC and low pH-RPLC 
using three standard proteins, α-casein, carbonic anhydrase, and cytochrome c. The 
standard proteins were loaded on the same column with different mobile phases (low pH 
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and high pH) individually. The elution time was normalized to the percentage of mobile 
phase B for direct comparison (Figure 2-1).   
 
 
Figure 2-1. The separation of three standard proteins. 
(A) low pH RPLC, and (B) high pH RPLC. The retention time was normalized to the 
percentage of mobile phase B. 
 
Under low-pH conditions, the elution order of the three standard proteins was Cyt, 
Cas, and CAH, while under high-pH conditions, the elution order was CAH, Cyt, and Cas. 
The change in elution order of the standard proteins indicates that under different pH 
conditions, different proteins will have different retention behaviors which provides the 
possibility of achieving orthogonal separation using low-pH RPLC and high-pH RPLC. In 
addition, we observed that the separation window under high-pH conditions was wider than 
that under the low-pH conditions. The separation window under low-pH conditions was 
about 12% MPB, and the separation window under the high-pH conditions was about 24% 
MPB further indicating the differences in retention behaviors of different proteins between 




Figure 2-2. Comparison of low-pH RPLC and high-pH RPLC as the first-dimension 
separation.  
(A) UV chromatograms SDS-PAGE using low-pH RPLC; (B) UV chromatogram and 
SDS-PAGE using high-pH RPLC. (C) Venn diagram of unique proteins identified using 
bottom-up proteomics. (D) Histogram of the fraction shift from low pH RPLC to high pH 
RPLC. 
 
We further evaluated the performance of the high-pH RPLC and the low-pH RPLC 
for separating complex protein mixtures such as E. coli intact proteins. For both RPLC 
separations, the same elution gradient (10-70% of MPB) was employed for direct 
comparison.  Figure 2-2 shows the elution profiles (UV chromatograms) of E.coli soluble 
intact proteins under different pH conditions.  The fractions from both low-pH RPLC and 
high-pH RPLC were analyzed by SDS-PAGE. A significant difference between the protein 
elution profiles was observed on both UV chromatograms and SDS-PAGE. All fractions 
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were analyzed by bottom-up MS for protein identification, and protein elution profiles were 
evaluated under different pH conditions (Figure 2-2). Overall, with bottom-up MS, a total 
of 678 unique proteins were identified using low-pH RPLC, and 840 proteins were 
identified using high pH RPLC with an overlap of 464 proteins between the two methods.  
The fraction shift was calculated to evaluate the orthogonality between different pH 
conditions (The fraction shift = the fraction number where the protein is most abundant 
under the high-pH condition – the fraction number where the protein is most abundant 
under the low-pH condition). Most of the identified proteins have a fraction shift larger 
than 2 (about 5% of the organic component), indicating good orthogonality between the 
two methods. Previous studies suggest that protein retention behaviors depend heavily on 
the composition of amino acids and their three-dimensional conformations.[78]  Five 
amino acids (Glu, Asp, Arg, His, and Lys) can be differentially ionized under different pH 
conditions. These five amino acids have either acidic side chains or basic side chains of 
which the polarities will be reversed when the conditions change from low-pH to high-pH. 
Thus, the retention behavior changes under different pH conditions and depends heavily 
on the ratio of these five amino acids in the sequence. Other than these five charged amino 
acids, all other types of amino acids have higher or similar retention coefficient under high-
pH condition than under low-pH condition.  Therefore, proteins are often eluted in later 
fractions under high-pH conditions, which is consistent with our observations (Figure 2-
2D).  Compared to the separation of peptides using a high-pH and low-pH RPLC platform 
reported by Gilar[70], the retention time shift of intact proteins was greater than the shift 
of tryptic-digested peptides, which may indicate that pH conditions have greater impacts 
on the hydrophobicity of proteins than that of peptides. We hypothesize that the large 
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properly folded proteins change properties more than small peptides because changing a 
single charge somewhere of a large protein can cause large conformational changes which 
will greatly affect retention behavior.  
We also compared the fraction width of each protein identified under high-pH and 
low-pH conditions (Fraction width refers to the number of fractions where a certain protein 
is identified). Fraction width under high pH is less than the fraction width under low pH, 
which is consistent with the greater identification number under high-pH conditions. Both 
the identification number and fraction width proved that RPLC with high-pH conditions 
provides similar or even better separation power than conventional low-pH RPLC, which 
shows high potential for high-pH RPLC as an orthogonal separation technique to yield high 
resolution 2D separations. 
One interesting observation was that under high-pH conditions, the retention 
behaviors of proteins seem to be less molecular weight dependent. According to previous 
reports [79, 80], larger proteins tend to have greater retention times in RPLC due to greater 
hydrophobicity under low-pH conditions.  One possible explanation of our observation is 
that protein charge distributions are different under different pH conditions. Basic amino 
acids such as Lys, Arg, and His are positively charged under low-pH conditions, and acidic 
amino acids such as Glu and Asp are negatively charged under high-pH conditions.  The 
location of these charged groups can have effects on protein elution. It has been reported 
that the proteins are more positively charged at their N-terminal and C-terminal, and more 
negatively charged at their core regions[81].  Therefore, there are less charges in the core 
regions under low-pH conditions and there are possibly more chain-length-dependence 
effects[82].  On the other hand, there are possibly more nearest-neighbor effects[83] on 
30 
 
protein elution due to neighboring negatively charged amino acids at their core region 
under high-pH conditions.  Still, the mechanisms of these proposed effects are unknown, 
and additional research is needed to further explore these observations. 
Overall, our results demonstrate the good orthogonality between low-pH RPLC and 
high-pH RPLC, which may be combined as a 2D separation approach for top-down MS 
analysis. The low-pH RPLC was selected as the second-dimension separation to directly 
couple with MS because the protein ionization efficiency is higher under acidic conditions 
and proteins tend to have higher charge state distributions that can be efficiently detected 
under the normal Orbitrap MS scan range (i.e., 400-2000). 
2.4.2  2D high-pH and low-pH RPLC-MS/MS analysis of E. coli intact proteins 
The two-dimensional separation platform using high-pH RPLC as the first 
dimension and low-pH RPLC as the second dimension was applied to the identification of 
complex E. coli proteins. To further evaluate the orthogonality between the 1st dimension 
separation and 2nd dimension separation, a total of 24 sequential fractions (i.e., 1-min per 
fraction, Figure 2-2A) were analyzed using the 2nd dimension RPLC-MS.  For future 
applications, the fractionation scheme can be optimized to justify the time investment and 
its benefits.  In addition, a targeted fraction analysis can be applied to increase the 
proteoform coverage of a specific protein or several proteins in a complicated background 
setting without significant increases in analysis time (i.e., with pre-fractionation, only 
several fractions need to be analyzed with 2nd RPLC-MS/MS reducing the total analysis 
time significantly).  
To evaluate the improvement from the 1D low pH RPLC to the 2D high- and low- 
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pH RPLC/MS platform, we analyzed E. coli intact proteins with 1D RPLC as well. Our 
results show that 2D pH-PRLC-RPLC separation allows better separation of protein 
mixtures with more proteins and proteoforms identified in the E. coli lysate.  A total of 365 
proteins and 886 proteoforms were identified with the 2D pH-RPLC-RPLC-MS/MS 
analysis, which is a significant improvement over 163 proteins and 328 proteoforms 
identified using the 1D RPLC method. An overlap of 121 proteins and 139 proteoforms 
between the 2D and 1D method was observed (Figure 2-3A and 2-3B).  
 
Figure 2-3. Identification results of the 2DLC. 
Venn diagram of numbers of (A) proteins and (B) proteoforms identified using 1D and 
2D methods. (C) Base peak chromatograms of 4 representative fractions. 
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However, there were some proteins that were only identified in the 1D RPLC-
MS/MS analysis. One possible explanation is that some proteins were unable to bind to the 
packing material under high pH conditions resulting in loss of identification of those 
proteins. A flow-through fraction will be incorporated in future studies to ensure the 
identification of unbound proteins.  
 
  
Figure 2-4. 2D pH RP/RPLC/MS analysis on E.coli proteins. 
(A) Base peak chromatogram of second dimension top-down analysis of fraction 19. (B) 
Representative mass spectra of three proteins identified in fraction 19. The three proteins 
are periplasmic protein, peptidyl-prolyl cis-trans isomerase A, and mono-oxygenase, 
subunit of predicted monooxygenase. (C) Overlay of observed isotopic distribution and 




The base peak chromatograms (BPCs) of individual fractions in the second 
dimension were evaluated (i.e., the BPCs of fraction 9, 12, 15, and 19 were demonstrated 
in Figure 2-3C). Figure 2-4 shows the examples of three identified proteins with isotopic 
distributions and molecular weight from 7.7 kDa to 18 kDa. For all 4 fractions, the BPC 
profiles indicated good orthogonality between different pH RPLCs because most of the 
proteins in these fractions were eluted out over the entire separation gradient (Figure 2-
3C). In addition, the BPCs of these 4 selected fractions have significantly different patterns 
as indicated in Figure 2-3C. These two observations further supported the good 
orthogonality between high pH RPLC and low pH RPLC.  
To further evaluate the improvement of top-down MS performance using 2D pH-
RPLC, the 5-minute segments (retention time from 90 minutes to 95 minutes) in the 
gradient of the 1D separation and the 2D separations of each fraction were compared 
(Figure 2-5). In the 1D RPLC-MS analysis, a total of 9 mass features were found in the 
selected 5-minute segment where6 unique proteins were identified. On the other hand, a 
total of 65 unique mass features were found in all the fractions in the 2D method, and 28 
unique proteins were identified. Some of the identified proteins were color coded in Figure 
2-5. A protein with the m/z of 1211.46 and charge state of 13 was identified in the 1D 
RPLC-MS analysis as a superoxide dismutase precursor (Cu-Zn) protein.  This protein was 
also identified in the fraction 17 of the 2D analysis. Interestingly, with the 2D separation, 
another precursor ion with similar m/z (i.e., m/z=1211.57) but different charge state (i.e., 
z=15) was observed in the same elution window in fraction 6 of the 2D analysis, which 
was confirmed as gi|251785751.  With 1D separation, only high-abundance proteins can 
be observed when the m/z of the detected ions are overlapping.  Due to less sample 
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complexity in the 2D method, more proteins can be identified, especially some low-
abundance proteins or from some overlapped peaks. The identification of intact proteins 
benefited from the orthogonality between the different pH RPLC separations. In addition, 
due to the improved separation power with the 2D pH-RPLC method, more proteoforms 
can be identified for the same proteins. For example, only one proteoform of the stress 
response protein (gi|251787301) was identified with the 1D RPLC method, however, 4 
different proteoforms (unmodified protein, lysine acetylation, methionine oxidation, and 
C-terminal degradation) were identified with the 2D method.  
 




It is known that the methionine residue can be oxidized through the interaction with 
molecular oxygen during sample processing steps.  Therefore, we compared the identified 
methionine oxidized proteoforms between the 1D RPLC-MS (280 min) analysis and the 
2D RPLC-MS analysis.  Overall, we detected 2 methionine oxidized proteoforms in the 
1D analysis, and 22 methionine oxidized proteoforms in 2D analysis. We further compared 
the intensities between the oxidized proteoforms and the non-oxidized proteoforms, and 
the average ratio was about 1:10 for both 1D and 2D. Our results do not suggest extensive 
oxidation arising from the additional processing steps and time in the 2D analysis.  Still, 
the detected proteoforms with oxidized methionine are likely from sample preparation 
steps such as cell lysis. 
Our 2D separation approach is relatively simple when compared with some other 
multidimensional separation approaches such as the GELFrEE [26] where an SDS removal 
step is necessary or and ion exchange chromatography where desalting step is often 
required before sample concentration.  The only step after fraction collection and before 
sample injection is that fractions are concentrated using vacuum drying where the frozen 
solution sublimes under vacuum (i.e., low oxygen level). 
2.4.3  Identification of novel intact proteoforms of apo-acyl carrier protein 
The apo-acyl carrier protein (gi|251784624) was identified in both the 1D and 2D 
methods. Apo-acryl carrier protein (ACP) is a unique protein working as a coenzyme in 
fatty acid and polyketide biosynthesis[84]. The protein is expressed in an inactive form. 
The phosphopantetheinyl transferase activates the protein after the expression by adding 
the phosphopantetheine moiety to serine 37 on ACP[85]. During the biosynthesis process, 
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the growing fatty acid chain is tethered to the thiol group of the phosphopantetheine on 
serine 37.  
 
Figure 2-6. Different proteoforms of apo-acyl carrier protein identified using 1D and 2D 
methods. 
 
From our 2D results, we identified both inactive and active forms of ACP, namely 
the protein with and without phosphopantetheine modifications (short as Pho-SH in Figure 
2-6) on serine 37 in the ACP sequence. Due to the improved separation, we were able to 
identify other low-abundance proteoforms, such as the proteoforms with and without N- 
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terminal methionine, the proteoform with an oxidation on methionine 45, etc. Interestingly, 
we also observed several novel proteoforms with different types of oxidized thiol groups 
of the phosphopantetheine on serine 37. We confirmed the proteoforms with Pho-SH, Pho-
SOH, Pho-SO2H, Pho-SO3H by the MS/MS results as well as by comparing the isotopic 
distribution of the detected peaks with the theoretical distribution (data not shown). 
Another oxidative proteoform was also confirmed as the glutathionylation on the thiol 
group of the phosphopantetheine on serine 37, which is a common non-enzymatic 
modification of cysteine thiol groups  resulting from oxidative stress and preventing 
irreversible oxidation of thiol groups[86-89]. Interestingly, all of the identified oxidative 
forms on the thiol group of the phosphopantetheine mimic the PTMs of cysteine thiol 
groups, which indicates the similar reactivity of these two types of thiol groups. One thing 
we would like to point out is that most of the different proteoforms of ACP were observed 
in one fraction (i.e., fraction 12), which indicates the modifcations on the thiol group of 
phosphopantetheine do not greatly affect the retention times of the protein. Using the 1D 
method, however, we only observed one proteoform as the active apo form of ACP with 
the removal of the N-terminal methionine. This enhanced identification of PTMs of ACP 
has convincingly proven that the 2D pH-RPLC-RPLC method improved proteoform 
identification by simplifying the complexity of the samples. All of the identifications of 
PTMs were characterized by MS2 spectra generated by collision induced dissociation. [17] 
Among all the 11 proteoforms of apo-acyl carrier protein in our study, we identified 
4 oxidized forms of the thiol group. We confirmed all of the Pho-S oxidative forms by 
MS/MS spectra.  Because the reactivity of the Pho-SH thiol group has not been studied 
before, it is difficult for us to conclude if the observed oxidative proteoforms are from the 
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sample process.  Interestingly, a proteoform with a free thiol group on phosphopantetheine 
was observed. Thiol groups normally have high reactivity in biological samples, especially 
with other thiol groups, forming disulfide bonds. It would be interesting to study on the 
function of the thiol group on the phosphopantetheine in the future. 
2.5 Conclusions 
We report the development and evaluation of a two-dimensional separation 
technique using a high- and low- pH RPLC/MS/MS platform for top-down proteomics. It 
achieves orthogonal separation by altering the pH conditions of the mobile phases while 
taking advantage of the high resolving power of RPLC. This allows the use of RPLC in 
both dimensions and offers higher resolution and better sensitivity than 1D techniques. 
From both the retention times of standard proteins as well as the bottom-up results of 
fractions from E. coli proteins using different pH RPLC’s, we have proven that altering the 
pH conditions of the mobile phases used in reversed phase chromatography changes the 
retention times of proteins in a useful manner. The platform was further applied to the 
identification of intact proteins in an E. coli lysate and it allowed the identification of 
greater numbers of proteins and showed higher proteoform coverage compared to 1D 
RPLC/MS top-down proteomics. This ‘salt-free’ RPLC process overcomes the 
disadvantage of other chromatographic methods which require complicated sample 
processing (i.e. buffer exchange, desalting) before MS analysis and provides the potential 
of easily coupling two dimensions of separation for online analysis. This is an important 




















*The materials in Chapter 2 are adapted from  
Wang, Z., Ma, H., Smith, K. and Wu, S., 2018. Two-dimensional separation using 
high-pH and low-pH reversed phase liquid chromatography for top-down proteomics. 
International journal of mass spectrometry, 427, pp.43-51. 
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Chapter 3 Development of an online 2D ultra-high-pressure nano-LC 
system for high-pH and low-pH reversed phase separation in top-
down proteomics 
3.1 Abstract 
The development of novel high-resolution separation techniques is crucial for advancing 
the complex sample analysis necessary for high-throughput top-down proteomics.  Ultra-
high-pressure long capillary column RPLC separation has been applied to top-down 
proteomics for the improvement of separation resolution because it allows the 
identification of hundreds of intact proteoforms from complex biological samples at low 
microgram sample amounts.  Recently, our group developed an offline 2D high-pH 
RPLC/low-pH RPLC separation method and demonstrated good orthogonality between 
these two RPLC formats. To further improve the throughput and sensitivity of the offline 
approach, we developed an online 2D ultra-high-pressure nano-LC system for high-pH and 
low-pH RPLC separations in top-down proteomics. A micro-trap column with an online 
dilution setup was used to collect eluted proteins from the high-pH separation and to inject 
fractions for ultra-high-pressure long capillary column low-pH RPLC separation in the 
second dimension. This platform enables the characterization of 1000+ intact proteoforms 
from 5 micrograms of intact E. coli cell lysate in 10 online-collected fractions. Here, we 
have demonstrated that our online 2D pH RP/RPLC system coupled with top-down 





Top-down proteomics analyzes intact proteoforms resulting from genetic 
variations, alternative RNA splicing, and post translational modifications [1]. Whereas 
bottom-up proteomics is robust and sensitive but provides limited information on 
proteoforms, top-down proteomics can provide a complete description of the primary 
structure of a protein and its modifications [90]. However, there are significant challenges 
posed to top-down proteomics by the complexity of protein samples [23]. Proteomes 
normally present a wide dynamic range of thousands of proteoforms, which makes the 
separation, accurate mass spectrometric detection, and data analysis extremely 
complicated. One of the major efforts to address these challenges is the improvement of 
separation resolution prior to MS analysis.  
Various separation techniques have been developed to be directly coupled to MS 
for high-throughput top-down proteomics, including RPLC [16, 18, 19] and capillary 
electrophoresis (CE) [91-94]. Multidimensional separation platforms have also emerged to 
improve the separation resolution of intact proteins from complex biological samples based 
on their orthogonal separation mechanisms [17, 21, 38, 39, 64, 91, 95-99]. Recently, our 
group reported the development of a 2D-LC platform that coupled high-pH RPLC to low-
pH RPLC for top-down proteomics. Fractions from the 1st-dimension high-pH RPLC were 
further separated using an ultra-high-pressure long capillary column for high-resolution 
low-pH RPLC-MS analysis. The offline platform was applied to characterize intact 
proteoforms from E. coli lysate [17] and from human HeLa lysate[100]. Our results 
suggested that orthogonal separation by altering the pH conditions of the mobile phases of 
RPLC was be achieved and the use of RPLC in both dimensions offered higher resolution 
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and better sensitivity than 1D-LC techniques. However, additional sample handling steps 
in offline 2D-LC often make the techniques lower-throughput, introduce degradation 
products, and result in poor sample recovery.  
Online 2D-LC has been developed to overcome some limitations of offline 2D-LC 
[19, 95, 96, 101, 102]. Recently, Baghdady et al. reported a proof-of-principle online 2D 
system that couples high-pH RPLC and low-pH RPLC for intact protein separation [101]. 
In Baghdady’s work, microflow RPLC columns were used in both dimensions and two 
sample storage loops were used for online coupling. In the 2nd dimension low pH RPLC 
separation, a very steep gradient (<1 min) was utilized which has been reported to enable 
the injection of sample volumes up to 70% of the column dead volume without band 
broadening for peptides and proteins [101, 103]. However, the separation resolution of the 
2nd dimension RPLC was relatively low, with a peak capacity of 19. This low resolution in 
the second dimension makes this approach less practical for improving proteoform 
identification without significantly improved 1st-separation resolution since online MS 
detection largely relies on decreased protein complexity eluted from the 2nd dimension 
RPLC.   
3.3 Materials and methods 
3.3.1 Chemicals and materials 
LC/MS grade acetonitrile (ACN), isopropanol (IPA), water, analytical reagent 
(AR) grade ammonium formate (AF), and acetic acid (HAc) were purchased from Sigma-
Aldrich (St. Louis, MO). Pierce™ Trifluoroacetic Acid (TFA), formic acid (FA), and 
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Pierce™ BCA Protein Assay Kit were obtained from Thermo Scientific (Hanover Park, 
IL). The packing material for packing C5 (Jupiter particles, 5 µm diameter, 300 Å pore 
size) column was purchased from Phenomenex (Torrance, CA), and the packing material 
for high-pH C4 columns was obtained from an ACQUITY UPLC Protein BEH C4 300 Å 
column (3.5 µm particles, 300 Å pore size, 4.6 mm × 100 mm) from Waters (Milford, MA). 
The 15,000 psi nano-volume 6-port switching valve and UPLC fittings were purchased 
from VICI Valco Instruments Co. Inc. (Houston, TX). Capillary tubing of different sizes 
was purchased from Molex (Lisle, IL). 
3.3.2 Sample preparation 
BL21 strain Escherichia coli (E. coli) cells were incubated in LB medium at 37 ℃ 
for 12 hours. The harvested E. coli cells were centrifuged at 10,000 × g at 4 ℃ for 10 
minutes to separate the cell pellets from culture medium. Cells were lysed using a high-
pressure homogenizer unit for 3 minutes (Avestin C3 EmulsiFlex homogenizer, pressure 
maintained between 1,500 psi and 2,000 psi). The cell lysate was then centrifuged at 10,000 
× g at 4 ℃ for 30 minutes to get rid of the cell debris.  The supernatant was desalted using 
a 3K MWCO filter tube (Amicon®, MilliporeSigma). The concentrations of the E. coli 
lysate were determined using BCA Protein Assay from Thermo Scientific. Aliquots of 
protein solutions were stored at -80 ℃ until further use. 
3.3.3 Instrumental setup of 1D-LC system 
All the 1D-LC experiments were performed on a modified Thermo Accela HPLC 
system as described in our previous work.[17] An in-house packed nano-flow capillary 
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column (75 cm, 75 μm I.D. × 360 μm O.D., C5, 5 μm particle size) was used.  The 
separation utilized 0.01% TFA, 0.585% HAc, 2.5% IPA and 5% ACN in water as mobile 
phase A, and 0.01% TFA, 0.585% HAc, 45% IPA and 45% ACN in water as mobile phase 
B. Twenty microliters of 0.25 μg/μL E. coli proteins were loaded on an SPE column (C5, 
5 μm, 150 μm I.D. × 5 cm) using an autosampler installed with a 25-μL sample loop. The 
sample was loaded onto the SPE with a flowrate of 6 μL/min for 15 minutes using buffer 
A, then the valve was switched to connect the SPE to the analytical capillary column for 
sample separation, where a 200-minute gradient from 10% A to 70% B at a flow rate of 
400 nL/min was applied. After the elution gradient, the gradient was ramped to 90% B and 
the column was flushed with 90% B for column washing. The gradient was then shifted 
back to 100% A to re-equilibrate the column for 20 minutes.   
3.3.4 Instrumental setup of online 2D-LC system 
The online 2D-LC platform was built using a Thermo Accela LC system (one 
autosampler, two Accela pumps), with two 6-port switching valves from Valco Instruments 
Co. Inc. (Figure 3-1 and 3-2).  The 1st dimension RPLC column (5 cm, 150 µm I.D. × 360 
µm O.D., Waters BEH C4 3.5 µm particles, 300 Å pore size), the 2nd RPLC column (75 
cm, 75 µm 8.D. × 360 µm O.D., C5, 5 µm particles), and the  SPE micro-trap column  (5 
cm, 150 µm I.D. × 360 µm O.D., Waters BEH C4, 3.5 µm particles, 300 Å pore size) were 
packed in-house. For high-pH RPLC separation, 20 mM ammonium formate in water  
(pH=10) was used as mobile phase A and 20 mM ammonium formate in acetonitrile 
(pH=10) was used as mobile phase B.  The pH values for buffers were adjusted with 
ammonium hydroxide.  (1) Sample loading: 5 μg of E. coli proteins was loaded onto the 
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1st dimension high-pH C4 column using an autosampler when the switching valve #1 was 
set at position A to allow the sample loop to be connected to the 1st dimension column.  
Meanwhile, the switch valve #2 was set at position A so the SPE micro-trap column was 
connected to the 1st dimension column to collect the flow-through fraction (e.g., proteins 
did not bind to the 1st dimension column); (2) Sample elution from 1st dimension column: 
The switching valve #1 was set to position B to bypass the sample loop after sample loading 
to 1D column. The first-dimension separation utilized step-gradient to elute the proteins 
from 1D column to the SPE. To enable the binding of eluted proteins from the first-
dimension separation to the 2D column, a flow from the 2D pump was used to dilute the 1D 
elution with a 1:10 dilution ratio. The flowrate was regulated using a splitting column to 
achieve a flowrate of 3 μL/min through the 1D column and a flowrate of 25 μL/min through 
the SPE. For each step, the proteins on the 1D column were eluted with a certain mobile 
phase B percentage range to the SPE at position A of the switching valve #2. (3) Sample 
separation and detection from 2nd dimension column: At 70 minutes, the switching valve 
#2 was switched to position B where the SPE was connected to the 2D column for second-
dimension separation. After that, the gradient of the second-dimension separation started 
at 10% B and ramped to 70% B over 200 minutes. Meanwhile, the first-dimension gradient 
was set back to 100% A. After the elution gradient, 270 minutes, the second-dimension 
gradient was set to 90% B to wash the 2D column for 10 minutes, and then back to 100% 
A to re-equilibrate the column. Repeating methods with different mobile phase B ranges 
for the first-dimension separation were applied to perform the online comprehensive 2DLC. 
The flow-through from the first-dimension separation was also analyzed after 2D separation. 
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3.3.5 Top-down MS analysis 
The analytes from LC separation were injected into an LTQ Orbitrap Elite mass 
spectrometer (ThermoFisher Scientific, Bremen, Germany) via a custom designed Nano-
ESI interface. The electrospray voltage was set to 2.6 kV and the inlet capillary temperature 
was optimized to 300 °C. The MS was set to a resolving setting of 120,000 (at m/z 400) 
with three micro scans with max ion time of 1,000 ms. The precursor ions were selected 
using an isolation window width of 6.0 under the data-dependent MS/MS acquisition mode 
where the top six most abundant precursor ions in the MS scan was selected. The selected 
precursor ions were fragmented using collision induced dissociation (CID) with a 
normalized energy of 35%. The MS/MS data were collected at a resolving power setting 
of 60,000 (at m/z 400) with three micro scans with max ion time of 500 ms. Ions with less 
than 4 charges were rejected for the selection of MS/MS scans. The dynamic exclusion was 
enabled where repeat count was set to 1, repeat and exclusion duration was set to 90 s with 
an exclusion list size of 500 count. The AGC target was set as 1 × 106 for full mass scans, 
and 3 × 105 for MS/MS scans. All the data were collected with Xcalibur 3.0 software 
(Thermo Fisher Scientific, Bremen, Germany). 
3.3.6 Data analysis 
The RAW files were converted into mzXML files with msconvert.[104] Top-down 
data were deconvoluted and searched against the annotated E coli. Database from UniProt 
using top-down mass spectrometry based Proteoform Identification and Characterization  
(TopPIC) suite[105] with the following search parameters: error tolerance for precursor 
and fragment masses was set to 15 ppm, the unexpected mass shifts were set to -500 to 
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500, maximum number of unexpected modifications was set to 2, the spectrum level and 
proteoform level cut off were both set to EVALUE less than 0.01.  TopPIC only reported 
one PrSM with the best E-value for each spectrum. To remove the redundant proteoforms, 
the proteoforms with mass differences less than 3.7 Da from the sample protein were 
manually evaluated and removed if they shared a sequence with a proteoform with a mass 
shift less than 3.7 Da. 
3.4 Results and discussion 
We have recently demonstrated a peak capacity of 200 for a single low-pH RPLC 
separation using an ultra-high-pressure long capillary column in top-down proteomics[16]. 
To further improve the separation resolution, here we report a microtrap column-based 
online 2D-LC platform using high-pH RPLC and low-pH RPLC separation with the ultra-
high-pressure long capillary column being used  in the low-pH RPLC separation. 
Nanoscale UPLC columns were also used in the 1st-dimension of high-pH RPLC to 
improve the sensitivity of the system. To operate these columns, ultra-high-pressure 
nanoflow pumps are often required. However, commercially available nanoflow UPLC 
systems are often expensive and hard to maintain. To provide an alternative affordable 
solution, we customized a high-pressure normal flow LC system with two Thermo Accela 
LC pumps (operational pressure 10,000+ psi, operation flow rate 10-1000 μL/min), two 
high-pressure 6-port switching valves and splitting columns [16], and one Thermo Accela 
autosampler. The schematic diagram of the online 2D system is shown in Figure 3-1. The 




Figure 3-1. The schematic diagram of online comprehensive 2D-LC platform.  
The setup of the online comprehensive 2D-LC. A 25-μL sample loop was installed on a 
valve in the autosampler. The 1D pump (high-pH mobile phase) was used to pumping the 
mobile phases for sample loading and first-dimension separation. The 2D pump (low-pH 
mobile phase) was used to provide dilution mobile phase to dilute the elution from the 
first-dimension separation, and to provide the gradient for second-dimension separation. 
A splitting column was used to regulate the pressure and flowrate of the SPE sample 
loading and first-dimension separation. 
  
Gradient setup for 1D: 
 
Figure 3-2. Stepwise operation of online 2D nano-LC system and the gradient setup. 
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In the 1st-dimension, we utilized a custom-packed 10 cm C4 capillary column 
(Waters BEH300, 3.5 μm, 300 Å, 75 μm I.D.) for high-pH RPLC separation (pH = 10). 
The eluate from the 1st-dimension was diluted online (1:10) and collected using a micro-
trap SPE column (Waters BEH300, 3.5 μm, 300 Å, 20 mm ×  150 μm). In the 2nd 
dimension, we utilized a 100 cm C5 column (Jupiter particles, 300 Å, 5 μm, 75 μm I.D.) 
for low-pH RPLC separation (pH = 2) that was directly coupled to an LTQ Orbitrap Velos 
Pro mass spectrometer for top-down MS analysis.  
 
Figure 3-3. Validation of the dilution factor for 2DLC analysis.  
The comparison of the base peak chromatograms of (A) 1DLC and (B) 2DLC analysis 
and the extracted ion chromatograms of two detected mass features from (C) 1DLC and 
(D) 2DLC analysis indicate that the eluate of the 1D separation can be efficiently diluted 
in a Tee with the dilution ratio of 1:10 (v/v). 
 
To evaluate the trapping efficiency of the micro-trap column (e.g., if the organic 
content was sufficiently diluted and pH was low enough for 2nd dimension RPLC 
separation), 5 μg of E. coli protein sample was injected onto the 1st-dimension column and 
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then directly eluted using 100% of high-pH mobile phase B to the trap column.  Both flow-
through and eluate were collected on the trap column during the trapping process. After 
trapping, the sample was separated using the 2nd dimension low-pH RPLC column for MS 
detection. The protein elution profile, protein intensity, and protein identification from this 
run were compared to a 1D low-pH RPLC separation of the same amount of E. coli protein 
sample (Figure 3-3). These results show that proteins can be efficiently eluted from the 
high-pH RPLC separation and trapped using the online micro-trap for the 2nd dimension 
low-pH RPLC separation. We further evaluated the reproducibility of the online 2D system 
with duplicated 2-fraction runs (1st-fraction is flow-through and 2nd fraction is eluate from 
0% to 100% buffer B) (Figure 3-4). The two 2D-LC runs had similar elution profiles in 
both flow-through and elution experiments. 
 
Figure 3-4. The online 2D chromatograms of 2-fraction runs. 
 
We then optimized the 1st-dimension fraction collection steps. An initial test of 11 
fractions (Figure 3-5) was evaluated with the following elution steps: 0% for 1st-fraction 
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and 0% to 10% for 2nd fraction followed by a 10% increase in the concentration of the 
elution buffer for each subsequent fraction. Analysis of intact E. coli cell lysate suggested 
that the majority of proteins were eluted in the range of 20% to 70% of mobile phase B of 
the 1st-dimension high-pH RPLC separation with the most mass features were detected in 
the fractions from 40% to 70% of mobile phase B.  
 
Figure 3-5. Evaluation of 1D gradient range for E. coli protein separation.  
Different percentage ranges of mobile phase were applied to elute the samples from the 
1D column. The eluates were separated and analyzed on the 2D column. 
 
Based on these observations, we combined 0% – 40% into one online fraction, and 
70% - 100% into another online fraction. The optimized a 10-fraction gradient setup for 
online 2D nano-LC was included in Figure 3-2 which was then applied to the 
characterization of intact E. coli proteins. The base peak chromatograms (BPCs) of the 2nd-
dimension low-pH RPLC-MS separation for each fraction are shown in Figure 3-6, 
demonstrating different elution profiles in different fractions. The BPSs of fractions after 
60% MPB of 1st-dimension present similar profiles. In last three fraction, there were only 
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87 unique proteoforms identified.  More precise optimization of gradient setup for different 
types of samples may be needed to better utilize the instrument time.   
 
Figure 3-6. LC-MS base peak chromatograms (m/z 600-1100) of the online 2D-LC 




Figure 3-7. Online 2D pH RP/RPLC MS analysis of E.coli proteins.  
(A) Base peak chromatogram of second dimension top-down analysis of online collected 
fraction 4. (B) Representative mass spectra of three proteins identified in fraction 4. (C) 
Overlay of observed isotopic distribution and theoretical isotopic distribution (red 
circles). 
 
Examples of three identified proteins with isotopic distributions are shown in 
Figure 3-7. To further evaluate the improvement of the online 2D-LC platform, we 
evaluated the 5-min 1D-LC gradient segment and the same retention time segment in each 
online 2D-LC collected fraction (Figure 3-8). Using 1D-LC, 19 mass features were 
detected in the 5-min separation window and 9 non-redundant proteoforms were identified. 
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Using online 2D-LC, we identified 24 unique proteoforms from 57 detected mass features 
in the 5-min segment in all the 10 online collected fractions. In total, 1,507 non-redundant 
proteoforms in 308 unique proteins were identified in 5 μg intact E. coli cell lysate with 
our online 2D separation, which is comparable with our previous reported results in 500 
μg intact E. coli cell lysate using the offline 2D separation [17]. 
 





We previously reported the identification of the apo-acyl carrier protein which is a 
unique protein working as a coenzyme in fatty acid and polyketide biosynthesis. Due to 
improved separation using the offline 2D pH RP/RPLC platform, low abundant 
proteoforms of the apo-acyl protein were characterized with the phosphopantetheine 
modification and its unique different oxidative forms of the thiol group on this 
modification. In this study, we were able to characterize most of the low abundant 
proteoforms of the apo-acyl protein using the online comprehensive 2D-LC platform 
(Figure 3-9). 
 
Figure 3-9.  Proteoforms of the apo-acyl carrier protein identified using offline 2D and 
online 2D pH RP/RPLC-MS. 
 
Despite the success of offline 2D high-pH/low-pH RPLC separations in bottom-up 
proteomics, there has been limited success for online 2D separation for bottom-up analyses. 
One major reason is that high-pH RPLC and low-pH RPLC are only partially orthogonal 
for peptide separations. Therefore, fraction concatenation is applied to more efficiently 
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utilize the separation space[106].  In top-down proteomics, as we discussed in previous 
offline studies, we observed good orthogonality between high-pH RPLC separation and 
low-pH RPLC separation. The improved orthogonality of the 2D platform allows efficient 
utilization of separation space without fraction concentration, which makes the online 
coupling of high-pH RPLC and low-pH RPLC feasible. We here evaluated the 
orthogonality between high-pH RPLC separation and low-pH RPLC separation with the 
developed online platform. For each “fraction”, a heatmap was generated using the relative 
number of uniquely identified proteoforms in each bin (10-minute windows) (Figure 3-
10). Our results suggest good orthogonality of the online 2D platform, which is comparable 
with the results from our previously reported offline 2D platform.    
 
Figure 3-10. The proteoform elution patterns in high pH fractions.  
Each column bin in the heatmap represents the relative count number of uniquely 





While offline fractionation is still the most commonly applied method, online 2D-
LC platforms offer the advantage of less sample loss and higher sensitivity, which enables 
the analysis of small quantity samples. In addition, since the online 2D-LC system is 
automated and no sample processing between the two dimensions is involved, artificial 
modifications such as degradation can potentially be reduced.  We here report the 
development of an online 2D ultra-high-pressure nano-LC system for high-pH and low-pH 
reversed phase separation for the top-down analysis of complex biological samples. With 
the online 2D system, small sample quantities could be analyzed to achieve comparable 
proteoform identification results with the offline 2D-LC using much higher starting sample 
amounts. Good orthogonality between 1st dimension high-pH RPLC and 2nd dimension 
low-pH RPLC were demonstrated using the online 2D system, which is consistent with our 
previously reports using the offline 2D system.  The performance of the proposed on-line 
2D system can be further optimized.  For example, the incorporation of duel trap columns 
could reduce the MS dead time in between runs through the parallel trapping and elution 
process[107].  Additionally, high-performance and high frequency MS instrumentation can 
be adapted for improved proteoform identifications in relatively shorter 2nd dimension 
gradient with columns using smaller particle size. Also, 1st dimension RPLC separation 
conditions such as buffer composition and column temperature can be optimized to 
improve the elution of hydrophobic proteins, which can increase column life and avoid 
back pressure problems. 
 
*Authors: Zhe Wang, Dahang Yu, Xiaowen Liu, Kenneth Smith, and Si Wu  
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Chapter 4 Top-down mass spectrometry analysis of human serum 
autoantibody antigen-binding fragments 
4.1 Abstract 
Detecting autoimmune disease at an early stage is crucial for effective treatment 
and disease management to slow disease progression and prevent irreversible organ 
damage. In many autoimmune diseases, disease-specific autoantibodies are produced by B 
cells in response to soluble autoantigens due to defects in B cell tolerance mechanisms.  
Autoantibodies accrue early in disease development, and several are so disease-specific 
they serve as classification criteria. In this study, we established a high-throughput, 
sensitive, intact serum autoantibody analysis platform based on the optimization of a one 
dimensional ultra-high-pressure liquid chromatography high-resolution top-down mass 
spectrometry platform (1D UPLC-TD-HRMS). Combined with our customized 
sequencing software, this approach has been successfully applied to a 12 standard 
monoclonal antibody Fab mixture, demonstrating the feasibility to separate and sequence 
intact antibodies with high sequence coverage and high sensitivity. We then applied the 
optimized platform to characterize serum autoantibody Fabs in a systemic lupus 
erythematosus (SLE) patient sample and compared it to healthy control samples.  From 
this analysis, we show that the SLE sample has many dominant antibody Fab-related mass 
features unlike the healthy controls.  To our knowledge, this is the first top-down 
demonstration of serum autoantibody pool analysis. Overall, our proposed approach holds 
great promise for discovering novel serum antibody biomarkers that are of interest for 
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diagnosis, prognosis, and tolerance induction, as well as improving our understanding of 
pathogenic autoimmune processes. 
4.2 Introduction 
Autoimmune diseases are a leading cause of death and disability in young minority 
women and collectively affecting more than 23.5 million Americans [108]. Many of the 
autoimmune diseases share similar symptoms, especially during the early stage of disease, 
which makes the diagnosis of autoimmune diseases extremely difficult[109]. Most 
autoimmune diseases are chronic conditions which can be controlled to varying extents by 
medication, but there is no permanent cure and these medications often leave the patient at 
increased risk of infection[110, 111]. Current researches increase the chances of more 
accurate diagnosis[46, 53, 54], however, many of the autoimmune diseases share similar 
serum biomarkers further contribute to an unreliable diagnosis[109]. Therefore, detecting 
systematic autoimmune diseases at an early stage is crucial for effective treatment and 
disease management to slow disease progression and prevent irreversible organ damage. 
However, this remains a significant clinical challenge due to the lack of unique biomarkers 
with both specificity and sensitivity.   
Autoantibodies are a hallmark of many autoimmune diseases and can be present in 
serum years before clinical symptoms arise[112] and are occasionally present even in 
healthy individuals[113]. Current analysis approaches only measure the total 
concentrations of the autoantigen specific autoantibodies that are often polyclonal and may 
contain highly homologous clonal sequences[45, 46]. However, the presence of specific 
autoantibodies in patients with autoimmune diseases is of interest for diagnosis, prognosis, 
60 
 
drug targets, and for our understanding of various disease processes.  DNA deep 
sequencing of the B cell antibody repertoire can be used to analyze humoral immune 
responses[114], but few of the detected sequences are represented in the circulating pool 
of serum immunoglobulins, and it is essentially impossible to determine which sequences 
are specific to an antigen of interest. To elucidate functionally relevant autoantibodies that 
mediate autoimmune responses, protein-level characterization of autoantibodies in the 
patient serum (i.e., proteomics) is needed to precisely determine which of these 
autoantibody clones are predictive of autoimmune disease progression. 
Mass spectrometry-based proteomics techniques have been used for the detection 
and characterization of serum monoclonal antibodies. Several bottom-up approaches have 
been developed to identify antigen-specific autoantibodies in serum [52, 53, 115].  These 
approaches often start with affinity purification of polyclonal autoantibodies from human 
serum with an autoantigen of interest. The purified antibodies are then digested with 
proteases such as trypsin to produce peptide fragments that are analyzed by LC-MS/MS.  
Identification of the peptide sequences corresponding to antibody fragments can be 
performed either with reference databases or through de novo sequencing.  In a very recent 
report, Gordon’s group demonstrated a possible “clonotypic sharing” by several shared 
peptide sequences in unrelated patients with SLE through bottom-up MS and de novo 
sequencing [46]. However, there are inherent challenges with bottom-up approaches for 
serum antibody analysis.  Serum autoantibodies are likely to be highly homologous with 
very similar sequences from common V gene families. Bottom-up proteomics on serum 
autoantibodies, starting with digested peptides, will result in a pool of peptides with both 
shared and non-shared sequences. Even assuming 100% sequence coverage (which is 
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nearly impossible to generate with bottom-up approaches), without additional information, 
bottom-up MS is unable to identify the precise coordination of individual sequences for 
each IgG. Moreover, the affinity purification of autoantibodies often requires extensive 
optimization processes, large initial sample volumes, selects for the highest affinity 
antibodies, and cannot provide a “bird-eye’s” view of the total autoantibody composition 
to all autoantigens in patient serum samples. 
Top-down proteomics has unique advantages in analyzing proteoforms with 
sequence variations and post-translational modifications (PTMs) because it analyzes intact 
proteoforms rather than short peptides. Recent developments in MS instrumentation and 
protein separation have paved the way for proteome-wide analysis of complex[61, 116]. A 
top-down proteomics approach (i.e., miRAMM) has been demonstrated for monitoring the 
light chain of a single monoclonal therapeutic IgG in spiked-in serum. Recently, the 
miRAMM was applied with the ultrahigh resolution MS (i.e., 21T FTICR-MS) and nano-
scale RPLC separation to analyze several spiked-in monoclonal antibodies in human serum 
offering the high mass accuracy and high sequence coverage[117]. However, because 
multiple autoantigens co-exist in autoimmune diseases, sera of autoimmune disease 
patients are very complex, likely containing at least hundreds of highly homologous 
monoclonal autoantibodies.  Thus, miRAMM or similar approaches cannot be directly 
applied to analyze serum autoantibodies without significantly advancing the analytical 
capability to separate many highly homologous autoantibodies from the serum antibody 
background.  In addition, advanced bioinformatics tools need to be developed to 
confidently sequence these autoantibodies. 
With top-down proteomics, reversed phase liquid chromatography (RPLC) is the 
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most commonly applied high throughput separation approach that can be coupled directly 
online with MS. Similar to bottom-up MS, longer column and higher pressure pumps are 
used to improve the peak capacity of RPLC separation[18].  We have previously reported 
a single-dimension top-down proteomics platform analysis with home-built nanoflow 
columns and Waters nanoAcquity pumps (maximum pressure 10,000 psi, operation 
pressure 7,000 psi)[29, 74, 118]. This platform identified 563 intact proteins in Salmonella 
including 1,665 proteoforms generated by posttranslational modification (PTMs) at 5% 
false discovery rate (FDR), representing one of the largest single-dimension top-down 
datasets reported to date[29].  In this study, we optimized an automatic single-dimension 
RPLC platform through a custom-modified ultra-high pressure nano LC system (UPLC, 
maximum pressure 14,000 psi, operation pressure 10,000 psi) to improve the separation of 
highly homologous autoantibodies (i.e., intact Fab’s, light chains, and heavy chains of the 
Fab portion) in serum samples. This approach has been successfully applied to a 12 
standard monoclonal antibody Fab mixture, demonstrating the feasibility to separate and 
sequence intact antibodies with high sequence coverage and high sensitivity. We then 
applied the optimized platform to characterize serum autoantibody Fabs in a systemic lupus 
erythematosus (SLE) patient sample compared to healthy control samples, showing that 
80+ dominant antibody Fab related mass features are only observed in the SLE sample, 
which is the first top-down demonstration of a serum autoantibody pool analysis.  
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4.3 Materials and methods 
4.3.1 Materials and Reagents 
LC/MS CHROMASOLV® grade isopropanol (IPA), acetonitrile (ACN), and water 
were purchased from Sigma-Aldrich (St. Louis, MO). Pierce™ Trifluoroacetic Acid (TFA) 
and Bond-Breaker™ TCEP Solution were obtained from Thermo Scientific (Hanover Park, 
IL). The packing materials for packing C5 (Jupiter particles, 5 µm diameter, 300 Å pore 
size) was purchased from Phenomenex (Torrance, CA). 
4.3.2 Human subjects 
SLE and healthy control plasma samples were obtained in accordance with the 
Helsinki Declaration and were approved by the Institutional Review Board at the 
Oklahoma Medical Research Foundation.  Blood was collected via venipuncture into ACD 
vacutainers (BD Biosciences, San Jose, CA), spun and the plasma was removed and stored 
at -20 oC until used.  The plasma from this particular SLE patient contains ~0.5 mg/mL of 
anti-Sm, as well as smaller quantities of anti-nRNP, anti-Ro and anti-La (data not shown).  
4.3.3 Monoclonal antibodies 
Fully human, full-length monoclonal antibodies were produced by the Human 
antibody core facility at the Oklahoma Medical Research Foundation as previously 
reported[119].  These antibodies were obtained from single cell-sorted antibody secreting 
cells or naïve B cells and are expressed with human IgG1 heavy chains and kappa or 
lambda light chains. 
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4.3.4 Sample preparation 
Escherichia coli cell lysate proteins were obtained from the BL21 strain grown in 
house. Cell lysate was obtained by bead-beating with zirconia silica beads[72]. Aliquots of 
protein solutions were stored at -80 oC until further use. Protein A/agarose beads were used 
for the antibody purification from serum samples. In detail, protein A beads were incubated 
with diluted plasma (3-5 ml total plasma, diluted 1:5 in 1 × PBS) at 4 oC overnight. The 
antibodies were eluted with 0.1 M glycine-HCl (pH 2.7) and concentrated using Amicon 
concentrators (30 kDa cutoff).  The purified IgG fractions, as well as standard monoclonal 
antibodies were then digested using insoluble papain suspension with incubation at 37 oC 
for 4 hours. After the incubation, protein A/agarose beads were used for the removal of Fc 
fragments from the antibody digests with the same conditions as previous described. Fab 
fragments from either plasma or monoclonal antibodies were then concentrated to > 1 
mg/mL total protein concentration with Amicon protein concentrators (10 kDa cutoff).  The 
Fab fragments were reduced by reacting with 1 μL of 0.5 M TCEP prior to the UPLC-TD-
HRMS analysis. 
4.3.5 UPLC-TD-HRMS 
An in-house packed nano-flow capillary RPLC-C5 column (5 μm, 75μm × 100 cm) 
was used on a custom modified UPLC (maximum pressure 14,000 psi) system. The mobile 
phase A was 0.01% TFA, 0.585% HAc, 2.5% IPA and 5% ACN in water, and the mobile 
phase B was 0.01% TFA, 0.585% HAc, 45% IPA and 45% ACN in water. Ten micrograms 
of E. coli lysate proteins, 8 micrograms of 12-antibody-Fab mixture, and 8 micrograms of 
purified human serum antibody Fab samples were loaded on the column for the top-down 
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MS analysis individually. A gradient from 10% to 70% of mobile phase B over 70 minutes 
or 280 minutes at a flow rate of 400 nL/min was applied for the separation and the column 
was regenerated by flushing with 90% of mobile phase B for 10 minutes and equilibrated 
to 100% of mobile phase A. The nano-LC column was directly coupled to an LTQ Orbitrap 
Velos Pro mass spectrometer (ThermoFisher Scientific, Bremen, Germany) for online 
MS/MS analysis with a custom designed nano-ESI interface under positive mode. The 
electrospray voltage was set to 2.6 kV and the heated inlet capillary temperature was 
optimized to 250 °C. MS data were collected at the resolving power setting of 100,000 (at 
m/z 400) with two micro scans. MS/MS acquisition was performed by selecting the top 
five most abundant precursor ions in the full MS scan using collision induced dissociation 
(CID) with the normalized energy of 35 %, higher-energy collisional dissociation (HCD), 
or electron-transfer dissociation (ETD). The MS/MS data were obtained at a resolving 
power setting of 60,000 (at m/z 400) with one micro scan. Ions with less than 4 charges 
were rejected for the selection of MS/MS scans. The maximum injection time for a full 
mass scan and a MS/MS scan were set to 1000 ms. and 500 ms., respectively. The AGC 
target was set at 1 × 106 for full mass scans, and 5× 105 for MS/MS scans. All of the data 
were collected with the Xcalibur 3.0 software (Thermo Fisher Scientific, Bremen, 
Germany).  
4.3.6 Data analysis 
The MS raw data were converted to centroid mzXML files with msconvert (a tool 
in ProteoWizard[104] and  deconvoluted with MS-Deconv[120]. A constant region 
sequence database (55 heavy, 5 kappa, and 13 lambda sequences) were downloaded from 
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the IMGT database[121]. The deconvoluted data were searched against the sequence 
database separately using TopPIC [105, 122], in which the error tolerances for precursor 
and fragment masses were 15 ppm and at most 2 unknown mass shifts were allowed in a 
proteoform spectrum-match. Other parameter settings in TopPIC can be found in Table 1.  
 
Table 4-1. Parameter settings of TopPIC in the analysis of the top-down MS/MS data of 
human serum samples 
Parameter Value 
Fragmentation method FILE 
Fixed modifications None 
N-terminal forms of proteins NONE, NME, NME+ACETYLATION 
Using a decoy database No 
Error tolerance 15 ppm 
Maximum number of unexpected mass 
shifts in a proteoform spectrum-match 2 
Spectrum level cutoff type E-value 
Spectrum level cutoff value 0.01 
Number of combined spectra 1 
E-value computation method Lookup table 
 
The filtered PrSMs were evaluated and filtered based on fragmentation patterns and 
matched signature sequence tags. The identifications are manually evaluated using 
ProSight Lite[123]. The detected mass features were deconvoluted using Informed 




4.4.1 Optimization of the UPLC-TD-HRMS platform 
  
Figure 4-1. Peak capacities of the LC-MS run of E.coli lysate proteins with different 
gradient length.  
(A) 280 minutes, and (B) 70 minutes. a, b, c, d, and e represent the randomly chosen 
peaks used for the calculation of the peak capacity. 
 
The 1D UPLC-TD-HRMS was developed and optimized using a Waters 
NanoAcquity HPLC system with the maximum pressure of 10,000 psi in our previous 
work[29, 73, 74, 118, 125, 126]. However, the routine operational pressure of the system 
was limited to 7,000 psi due to commercial system limitations and automation. The 
operational pressure often changes with the organic components in the elution buffer, and 
the run would be interrupted when the pressure reached the maximum pressure. Recently, 
Shen et al. demonstrated high peak capacities in long-column RPLC separation at ultra-
high pressure operation pressure (maximum operation pressure at 14,000 psi) using a 
manually operated constant pressure syringe pumps with customized gradient mixers[18]. 
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To improve the throughput for long-column RPLC separation at higher operation pressure 
limits, we modified a commercially available normal-flow system (e.g., Thermo Accela 
pumps, maximum pressure 14,000 psi) through the customized splitting system to establish 
an automatic UPLC system that can be routinely operated at a pressure higher than 10,000 
psi for long-column nano-LC separation (e.g., operation flow rate between 200 nL/min to 
400 nL/min).  
The elution gradient of the customized UPLC system was optimized using a custom 
packed C5 long column (e.g., C5, 100 cm length, 360 µm o.d., 75 µm i.d.). Ten micrograms 
of E. coli lysate proteins were loaded on the column and an elution gradient from 10 % to 
70% of mobile phase B was applied over 70 minutes and 280 minutes separately. The peak 
capacities with different gradient times were calculated by comparing the base peak widths 
of five randomly selected proteins from the LC/MS runs (Figure 4-1). The average base 
peak widths were 1.08 minutes for a 70 minute-gradient and 1.41 minutes for a 280 minute-
gradient, respectively. The peak capacity of a 70-minute run was calculated as 66, and the 
peak capacity of a 280-min run was 200. Our results suggested that the peak widths did not 
increase significantly with the gradient length was increased. With the ultra-high pressure 
applied, the improved resolution of the separation from longer columns can partially 
overcome the resolution loss from the diffusion with the longer separation time. Based on 
the results, we here chose 280 minutes as the gradient time (10% - 70% of mobile phase 




4.4.2 UPLC-TD-HRMS analysis of a 12-antibody mixture 
To evaluate the capacity of the separation and identification of intact antibody Fabs 
using the optimized UPLC-TD-HRMS platform, we papain-digested 12 fully human 
monoclonal antibodies and enriched the Fab fragments using protein A agarose beads as 
described above.  These 12 Fabs were mixed in equal quantities and eight micrograms of 
the 12-Fab mixture was reduced by TCEP and loaded on the column for top-down MS 
analysis.  
 
Figure 4-2. LC-MS of 12 standard antibody mixture.  
(A) Base peak chromatogram of the LC-MS. (B) Extracted ion chromatograms of light 
chains and heavy chains from 4 standard antibodies. (C) Mass spectra of the 4 light 




Figure 4-2A shows the base peak chromatogram of the separation of the 12-Fab 
mixture as well as the extracted ion chromatograms (Figure 4-1B) of the light chains and 
heavy chains for each Fab fragment.  Overall, the Fab light chains eluted earlier (between 
27% and 30% B) compared with the Fab heavy chains (between 27% and 38% B). 
Combined with high-resolution MS spectra and online MS/MS spectra, most of the 
standard antibody Fabs can be confidently assigned.  Representative high-resolution MS 
spectra were demonstrated for 4 light chains and 4 heavy chains (Figure 4-1C). Our 
analysis demonstrated the feasibility of separating reduced intact Fab fragments in complex 
samples such as serum autoantibodies. 
  
Figure 4-3. The identifications of the Fab light chain and Fab heavy chain of an antibody.  
Different fragmentation methods (e.g. HCD and ETD) were used to improve the 
sequence coverage. Examples of the MS/MS spectra of Fab light chain and Fab heavy 





Different dissociation methods available on commercial orbitrap instruments were 
applied to the online fragmentation of proteins ions, including collisional induced 
dissociation (CID), higher-energy collisional dissociation (HCD), and electron transfer 
dissociation (ETD). The combination of different dissociation methods can significantly 
improve the sequence coverage of reduced Fab fragments. The representative Fab fragment 
was well characterized with 51% residue cleavages (67% for light chain and 40% for Fab 
heavy chain) (Figure 4-3). All of the MS/MS spectra used for Fab identification were 
manually checked and confirmed.  
Analysis of Fabs with proper heavy and light chain pairing is crucial for antigen-
binding studies of antibodies and this cannot be achieved with reduced samples. Therefore, 
the intact Fab fragment mixture (no reduction) was also analyzed using the UPLC-TD-
HRMS platform. We have optimized our current Velos Orbitrap Pro’s performance and 
were able to partially resolve intact non-reduced Fabs (e.g., M.W. ~48 kDa).  The results 
(Figure 4-4) indicated that intact non-reduced Fabs can be efficiently separated and 
analyzed using our developed UPLC-TD-HRMS platform.  The detected masses from the 
non-reduced samples were used to pair the light chain and heavy chain masses detected 
from the reduced samples  (Figure 4-4B).  Our results demonstrated that the developed 
UPLC-TD-HRMS platform is capable of separating and characterizing antibody Fab 
mixtures (both reduced and non-reduced) with high similarities, which can be applied to 




Figure 4-4. Analysis of reduced and intact Fab fragments. 
(A) Base peak chromatogram of one LC-MS/MS run of the intact Fab mixture. Two 
examples of the detected mass spectra.  (B) One example of light chain and heavy chain 
pairing. The mass spectrum of the intact Fab was from the LC-MS/MS run of the 12 
intact Fab mixture. The detected mass was compared with all the detected masses from 
the LC-MS/MS run of the 12 reduced Fab mixture to obtain the LC/HC pairing. 
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4.4.3 UPLC-TD-HRMS analysis of monoclonal antibodies in human serum 
With the optimized platform, we analyzed several human serum samples and 
characterized higher abundance antibodies that we suspect are autoantibodies in the serum 
with the ability to determine the light chains and heavy chains.  Three serum samples were 
obtained from a SLE patient at different time points and the control samples were obtained 
from two healthy control individuals (autoantibody negative). All of the serum samples 
were purified using Protein A beads to enrich the antibodies from serum. After the 
enrichment, the samples were papain-digested and Fc portions were removed by Protein A 
beads. The purified Fab mixtures were reduced with TCEP and analyzed using the 1D 
UPLC-TD-HRMS platform. We first evaluated the summed MS spectra among different 
samples (Figure 4-5A).   
 
Figure 4-5. LC-MS analysis of SLE serum sample and healthy control samples.  
(A) Summed mass spectra of control samples and the SLE serum sample. Deconvoluted 
mass features from 22,500 Da to 25,000 Da from different samples. Comparison between 
(B) two control samples, (C) SLE serum and one of the control samples. Some of the 
mass spectra of the deconvoluted mass features were also shown above. 
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For control samples, the summed spectra showed a wide range of unresolved 
normal distributed peaks similar to previous reports.  For the SLE sample, several mass 
features were observed, indicating possible presence of autoantibodies. The UPLC-MS 
datasets were then deconvoluted to generate a “bird’s-eye” view on the total autoantibody 
composition in patient serum samples.  Figure 4-5B and 4-5C showed the deconvoluted 
mass features between 22,500 Da to 25,000 Da, representing the molecular weight range 
of both Fab heavy chains and Fab light chains. In the control samples, most of the 
deconvoluted mass features have low intensities and are not well-resolved (i.e., less than 
1E5 with the S/N less than 2).  In control sample 1 (Figure 4-5B), we observed 4 mass 
features with relatively good S/N ratios.  We manually averaged the related scans for these 
mass features, and all of them have good isotopic distributions that can be putative Fab 
chains. These putative Fab chains are less likely from autoantibodies because these control 
serum samples tested negative against all known autoantigens, but they are likely from 
ongoing immune responses.  Moreover, the measured intensities of these putative Fab 
chains are relatively low (i.e., less than 2E5).  We further compared one of the SLE serum 
samples with one of the control samples (Figure 4-5C). In the SLE serum sample, 40 mass 
features were confidently detected with the total intensity larger than 1E6.  All of these 
mass features are manually evaluated to ensure that they stood out from the serum antibody 




Figure 4-6. Identification of light chains and heavy chains of the IgGs in SLE Patient 
Serum.  
(A) Plotting of the distribution of the detected mass features in one of the SLE patient 
serum samples. (B) MS/MS identification of one kappa 1 immunoglobulin light chain. 
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The detected mass features were deconvoluted and plotted against the LC elution 
time (Figure 4-6A). Mass spectra and EICs of two representative detected mass features 
are also shown in the figure. Baseline resolved monoisotopic distribution of the detected 
mass feature was achieved and the EIC showed the high resolution of the UPLC-TD-
HRMS platform even with extreme complicated and similar background serum antibodies. 
In order to identify the detected mass features, we first used our customized sequencing 
software to perform a database search, and 20 PrSMs were confidently identified as either 
light chains or heavy chains of intact Fabs. After manually checking the MS/MS spectra, 
we noticed a common pattern in all detected light chain MS/MS spectra. The sequence tag, 
VFIFPP, was confidently identified in all MS/MS spectra of the light chains, which was 
then applied as the criteria of the mass features being light chains. One of the identified 
light chain from the SLE patient serum sample was shown in Figure 4-6B. The constant 
region of the light chain was well characterized with fully cleavage site coverage of the 
desired region (VFIFPP). Thus, in the filtered PrSMs, a mass feature was assigned as a 
light chain if more than two product ions of VFIFPP were observed. In addition, we 
manually analyzed the identified CID MS/MS spectra and confirmed 9 of them as intact 
Fab light chains in the SLE serum sample. We further performed the UPLC-TD-HRMS 
analysis on two additional SLE serum samples from the same patient.  Overall, we 
confidently detected 80+ unique mass features in the putative Fab range in samples from 3 
different years.  The collected MS/MS raw data were processed with TopPIC and IMGT 
database[121] was used to search the data.  Manual evaluation was also performed to 
ensure the quality of the identifications. In total, 47 unique light chains and 16 unique heavy 
chains were identified in the samples from one SLE patient collected over three successive 
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years. Both biological and technical duplicates were also performed to evaluate the run-to-
run reproducibility. The biological duplicate samples of SLE serum samples collected in 3 
different years were obtained by performing the same Fab produce process described above 
and analyzed by the developed platform. All of the detected mass features were evaluated 
manually. The detected mass features from each run were then compared showing in 
Figure 4-7A.  Technical duplicates were performed as well. Figure 4-7B shows the 
overlap of the detected mass features from two runs of year 3 sample. From the result, the 
platform was proven to be highly reproducible between technical duplicates where run 1 
and run 2 of year 3 sample shared 39 detected mass features out of 47 and 43 detected mass 
features, respectively. Biological duplicates of the 3 samples also showed good 
reproducibility. However, the overlap between the biological duplicates of year 1 sample 
showed small overlap. One of the possible reasons is the difference brought in during the 
sample process. Overall, the overlap between biological duplicates was over 50%. 
 
Figure 4-7. Run-to-run reproducibility of the developed platform.  
(A) The overlaps between biological duplicates of samples collected in different years are 
shown above. (B) The technical duplicate of the sample from year 3 is also compared 




We developed and optimized a single dimensional UPLC-Top-down-High 
resolution mass spectrometry platform (UPLC-TD-HRMS) for the separation and 
characterization of autoantibodies in human serum. The UPLC-TD-HRMS platform 
provided sufficient separation of complicated antibody Fab mixtures and comprehensive 
characterization of Fab for light chain/heavy chain classification with high mass accuracy, 
high run-to-run reproducibility and in a high-throughput manner. To achieve better LC and 
mass resolution on our accessible instruments, the Fab fragments were reduced. However, 
due to the reduction of disulfide bonds, the light chain and heavy chain pairing information 
cannot be preserved with one LC-MS/MS analysis, but it is possible to regain this 
information by LC-MS/MS analysis of intact Fab fragments.  
Using our platform, we were able to identify a total of47 light chains and 16 heavy 
chains from SLE patient serum. To our knowledge, this work is the first, to date, top-down 
MS demonstration of the human serum autoantibody pool analysis enabling the 
classification of light chains and heavy chains, which gives us a ‘bird’s-eye’ view of the 
complexity of human serum autoantibodies. Our results showed the potential of using high 
resolution separation methods coupled to high resolution and highly sensitive mass 
spectrometry detection to help the understanding of human serum autoantibodies. Future 
studies can be done to improve the LC separation resolution of larger proteins, such as 
multidimensional separation techniques[127]. We note that currently selected patient 
samples are from a patient with advanced disease. More sensitive separation approaches 
such as capillary electrophoresis[128] and targeted approaches can be incorporated for 
early stage autoantibody detections. High-end mass spectrometers (i.e., 21T FTICR-MS) 
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with different fragmentation techniques, such as front-end electron transfer 
dissociation[129] and Ultraviolet Photodissociation (UVPD)[130], can also be applied to 
increase the mass detection range and mass accuracy.  
One of the challenges of serum autoantibody sequencing and characterization is the 
complexity of human antibody repertoire. The DNA sequencing of B-cells from particular 
patient can be performed to enlarge the existing database for more identifications of 
antibodies in human serum samples. In addition, we also observed some of the MS/MS 
spectra with good quality fragmentation were not identified which might be another result 
of the incomplete database. Another reason may relate to the sequencing software. In future 
works, the optimization of the sequencing software can also be done to expand the 
identifications. Our results, overall, demonstrated the ability of our platform performing 
top-down MS analysis on complicated human serum samples and detecting antibodies 
developed in patient serum over years, which gives it the possibility to monitor the 





*The materials in Chapter 4 are adapted from  
Wang, Z., Liu, X., Muther, J., James, J.A., Smith, K. and Wu, S., 2019. Top-down 
Mass Spectrometry Analysis of Human Serum Autoantibody Antigen-Binding Fragments. 
Scientific reports, 9(1), p.2345. 
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Chapter 5 Optimization of a subzero temperature LC separation in 
hydrogen/deuterium exchange mass spectrometry for 
conformational epitope mapping 
5.1 Abstract 
Hydrogen deuterium exchange coupled with mass spectrometry (HDX-MS) 
provides a powerful and desirable protein foot-printing method to monitor protein 
dynamics and protein-protein interaction.  In HDX-MS, sub-zero temperature LC 
separation has been developed to minimize the back-exchange and maintain a high-
sequence coverage, which are crucial aspects for HDX-MS analysis.  We here optimized 
the LC separation for HDX-MS using different mobile phases under different subzero 
temperatures with the tryptically digested E. coli cell lysate.  The back-exchange rates were 
evaluated by comparing the theoretical maximum deuterium uptake to the detected mass 
of each identified peptide using customized software. The optimized sub-zero temperature 
RPLC platform (i.e., -9 ℃, water/acetonitrile-based buffers, 10,000 psi) was then used to 
characterize the conformational changes in the anthrax protective antigen (PA) and its 
known antibody complex samples. We identified a potential binding site of the PA and one 
anti-PA antibody. Furthermore, we performed the same technique to characterize the 
binding sites of PA and two different anti-PA antibodies in a one-pot sample, showing the 
potential of the sub-zero temperature RPLC HDX-MS platform to identify site-specific 





Proteins are of great importance in every living organism. They perform a variety 
of essential functions in different biological processes such as immune response, energy 
conversion, transport, catalysis, etc. [131]. The functionality of a protein depends on the 
structures and dynamics of that protein; thus, understanding the structures and dynamics 
of proteins is essential to the studies of protein functions.  Hydrogen deuterium exchange 
mass spectrometry (HDX-MS) has become a promising technique for characterizing 
protein structure and dynamics, as well as protein/protein interactions [132]. HDX-MS 
monitors the exchange of protein backbone amide hydrogens to deuterium to reveal 
conformational information regarding the structures of proteins or protein complexes. 
HDX-MS technique is complementary to traditional structural biology techniques such as 
X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryogenic 
electron microscopy (cryo-EM) [133, 134]. However, protein crystals are required for X-
ray crystallography, purified protein is required for NMR techniques, and special sample 
treatment is needed for cryo-EM techniques. The crystallization of proteins is normally 
time consuming and X-ray crystallography and NMR techniques are limited to small size 
proteins[135]. Compared to these traditional structural biology methods, HDX-MS offers 
the advantage of simple sample preparation, which only requires D2O to produce label 
proteins. Additionally, since the deuterated proteins are digested into small peptides for 
MS or LC-MS analysis, HDX-MS can be applied to analyze large proteins, which is 
difficult to achieve using other methods [136]. Furthermore, HDX-MS also has minimal 
background matrix effect, which means that it can be applied to analyze proteins of interest 
in complex samples [133].  
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HDX-MS, however, does offer its own drawback including the sensitivity of 
deuteration to experimental conditions such as pH and temperature. Therefore, careful 
optimization and control of HDX experimental conditions is essential to deliver a reliable 
and unbiased result [133, 137]. Another issue in the implementation of HDX-MS is the 
back exchange of deuterium with hydrogens from the solvent after quenching, during 
protein digestion, reduction, and LC separation [138]. Hydrogen back-exchange affects the 
measurement of amide hydrogen exchange rates which results in loss of site-specific 
information and can bias the identification of sites of interest.  
Extensive efforts have been made to optimize the HDX experimental conditions, 
especially the conditions of post HDX quenching steps, to minimize the back-exchange of 
deuterium [138-141]. These efforts include low-pH and low-temperature protein digestion 
[142] and fast chromatographic separation at low temperature (e.g. 0 ℃) [143, 144]. 
However, fast chromatographic separation limits the identification of peptides, reduces 
sequence coverage, and cannot sufficiently separate complex samples. The loss of site-
specific information may impede the identification of binding sites if the corresponding 
peptides cannot be identified.  To minimize back-exchange during longer chromatographic 
separation sub-zero temperature LC for HDX-MS has been developed and evaluated [138, 
139]. Bai and Englander have demonstrated that decreasing the temperature of separation 
from 0 to -30 ℃ can effectively reduce the deuterium exchange rate by about 40-fold[145]. 
With appropriate mobile phase modifier, to prevent the mobile phase from freezing, 
reversed phase liquid chromatography (RPLC) at sub-zero temperature demonstrated a 
negligible loss of deuterium.  
We here evaluated LC separation at subzero temperatures using different mobile 
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phases to minimize the back exchange and maintain a high sequence coverage.  The 
optimized sub-zero temperature (i.e., -9 ℃) RPLC separation system were used for the 
HDX-MS of the antibody-antigen interactions of the adaptive immune system (i.e., anthrax 
protective antigen (PA) and the interactions of various anti-PA antibody complex 
mixtures). We have identified a potential binding site of PA with one anti-PA antibody and 
characterized the binding sites of PA with two different anti-PA antibodies in a one-pot 
sample. Clear characterization of paratope/epitope interaction of an immune complex can 
further the understanding of immune response and possibly elucidate the mechanisms of 
immune diseases [146, 147]. Moreover, our results demonstrate the potential of a sub-zero 
temperature RPLC HDX-MS platform to identify site-specific interactions in complex 
samples. 
5.3 Material and methods 
5.3.1 Materials and reagents 
All chemicals, including Protease Type XIII from Aspergillus saitoi (≥0.6 unit/mg) 
and Deuterium oxide (≥99.6 atom % D), were purchased from Sigma-Aldrich (Milwaukee, 
WI) unless noted otherwise. Phenylmethylsulphonyl fluoride (PMSF) was purchased from 
VWR (Radnor, PA) and trypsin (TPCK treated) was obtained from ThermoFisher 
(Rockford, IL). The desalting column, Strata C18-U (55 μm, 70 Å, 100 mg/mL) was 
purchased from Phenomenex (Torrance, CA). An ACE® Excel® SuperC18™ column (100 
mm × 2.1 mm, 1.7 μm, 90 Å) was purchased from Advanced Chromatography 
Technologies Ltd (Aberdeen, Scotland). 
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5.3.2 Sample preparation 
Escherichia coli (E. coli) K12 cells were grown in 2% LB media and cultured at 37 
°C with gentle shaking at 250 rpm overnight. The cultured E. coli was collected and 
centrifuged at 13,000 rpm for 60 minutes. The supernatant was discarded, and the resulting 
E. coli pellets were resuspended in 25 mM ammonium bicarbonate at a ratio of 1 gram of 
cell pellets to 5 mL of buffer. 0.1% (v/v) PMSF was added to inhibit the protease from 
degrading proteins. Then, the E. coli pellets were lysed using EmulsiFlex-C3 homogenizer. 
The cell lysate was then centrifuged at 4 °C at 13,000 rpm for 60 minutes to remove cell 
membrane. The proteins in the supernatant were denatured using 6 M urea and reduced 
using 200 mM dithiothreitol and 200 mM iodoacetamide. The proteins were then digested 
with trypsin at 37 °C overnight with a protein to enzyme ratio of 50:1 (m/m). The peptides 
were then desalted using solid phase extraction columns and vacuum dried. Non-deuterated 
E. coli peptides were prepared by reconstituting the vacuum dried peptides into LC-MS 
grade water to a concentration of 1 μg/μL. Fully deuterated E. coli peptides were prepared 
by reconstituting the vacuum dried peptides into D2O to a concentration of 1 μg/ μL and 
incubated at room temperature for three days.  
5.3.3 Low-temperature liquid chromatography 
Low-temperature liquid chromatography was achieved by placing a six-port valve 
and a C18 RPLC column (100 mm × 2.1 mm, 1.7 μm, 90 Å) in a portable freezer. The 
temperature of the portable freezer can be controlled at a range from 20 °C to - 20°C. Two 
different mobile phase systems (mobile phase system 1 and 2) were utilized to avoid 
freezing of solvent in the LC system. Mobile phase system 1 was made up of 89.9% HPLC 
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water, 10% acetonitrile, and 0.1% formic acid for mobile phase A and 99.9% acetonitrile 
and 0.1% formic acid for mobile phase B. Mobile phase system 2 was made up of 64.9% 
water, 35% methanol, and 0.1% formic acid for mobile phase A and 99.9% acetonitrile and 
0.1% formic acid for mobile phase B.  
LC separation performance of the two different mobile phase systems were 
evaluated using E. coli digest and detected with a photodiode array (PDA) detector. For 
mobile phase system 1, 25 μg of non-deuterated E. coli lysate peptides were manually 
injected into the LC system at room temperature, 4 °C and -9 °C. The flow rate was 150 
μL/min. The gradient started with 0% mobile B for sample loading over 10 minutes 
followed by an increase from 0% to 35% mobile phase B over 30 minutes for peptide 
separation. Then the column was washed by 90% mobile phase B for 5 minutes, followed 
by a decrease to 0% mobile phase B in 3 minutes. The column was re-equilibrated by 
flushing with 100% mobile phase A for 10 minutes. For mobile phase set 2, the same 
sample and gradient procedures were used, except mobile phase B was ramped to 40% 
instead of 35% over 30 minutes for peptide separation. Mobile phase system 2 was also 
evaluated at -20 °C.  
The back-exchange rates of the two different mobile phase systems at different 
temperatures were evaluated using fully deuterated E. coli digest and detected using MS. 
25 μg fully deuterated E. coli lysate peptides were manually injected into LC system at 
room temperature, 4 °C, -9 °C, and -20 °C. Mobile phase system 1 and 2 were both used 
for room temperature, 4 °C, and -9 °C. Mobile phase system 2 was used for -20 °C.. A 
longer gradient, 10% mobile phase B to 40 % mobile phase B over 90 minutes with a flow 
rate of 150 μL/min, was also applied to evaluate the back-exchange of fully deuterated E. 
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coli peptides.  
5.3.4 Hydrogen/Deuterium Exchange 
Differential HDX experiments were performed for PA epitope mapping. 6 μM PA 
was prepared by diluting 12 mM PA into HPLC water at a ratio of 1:1 (v/v). The PA and 
anti-PA antibody immunocomplex sample was prepared by premixing 12 μM PA with 15 
μM anti-PA antibody at ratio of 1:1 (v/v) at room temperature. For deuterium labeling, 4 
μL of free PA sample and 4 μL of complex sample were diluted with 20 μL of D2O and 
incubated for 3.5 minutes at room temperature, individually. Experiments were conducted 
in triplicate. The deuteration was quenched by adding 24 μL of chilled 1% formic acid to 
a final pH of 2.4 and incubated at 0 °C for 2 minutes. The quenched solution then was 
incubated with 48 μL of 1.2 mg/mL protease XIII at 0 °C for 4 minutes for protein 
digestion. The digested peptides were quickly injected into the low-temperature LC system 
with a gradient from 0% to 35% mobile phase B over 30 minutes at -9 °C followed by mass 
spectrometer analysis. 4 μL of 6 mM PA sample was incubated with 20 μL of H2O, 
followed by same quenching, digestion, LC separation, and MS analysis steps for peptide 
identification.  
5.3.5 Bottom-up MS analysis 
An LTQ Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Hanover 
Park, IL, USA) with a custom nano-ESI interface was used for LC-MS/MS. The heated 
capillary temperature was set to 275°C with a spray voltage of 3.5 kV. MS scans were 
obtained using the Orbitrap MS with a resolution setting of 100,000 and m/z range from 
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350 to 1350. The AGC was set to 5E6 and the max ion time was set to 1000 ms with 2 
micro scans. MS/MS scans were acquired using the LTQ MS with collisional induced 
dissociation (CID) at a normalized collision energy setting of 35%. The ten most abundant 
precursor ions were selected for MS/MS. The AGC for MS/MS was set to 1E6 and the max 
ion time was set to 1000 ms with 2 micro scans.  
5.3.6 Data analysis 
5.3.6.1 Peptide identification 
Non-deuterated E. coli lysate peptides were identified using MSGF+ to search the 
mass spectra from the LC-MS/MS analysis against the annotated E. coli database and its 
decoy database. The peptide identifications were filtered using a SpecE cut-off value of 
1E−10 (i.e., the calculated FDR <1% at the unique peptide level). 
5.3.6.2 Deuterium uptake calculation 
 Deuterium incorporation of peptides was calculated using the in-house developed 
software. Deuteration level of each peptide was calculated as shifted weighed mass of each 
peptide divided by the total number of exchangeable amide hydrogens [148]. 
5.4 Results and discussion 
5.4.1 Evaluation of low-temperature RPLC separation 
RPLC is often performed at room temperature or higher for more efficient mass 
transfer of analytes to achieve better separation. The RPLC mobile phase A utilizes water 
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which has a freezing point of 0 ℃. To operate LC under sub-zero temperatures, mobile 
phase modifiers can be used to decrease the freezing points of mobile phases to avoid 
freezing the LC system. The modifiers should have good electrospray efficiency to 
minimize the effects on the sensitivity of MS detection. Ethylene glycol, dimethyl 
formamide, formamide, and methanol have been previously used as mobile phase 
modifiers [139]. We chose methanol as the modifier to perform LC at -20 ℃ because 
methanol has good electrospray efficiency and low hydrophobicity which should have a 
limited impact on the separation resolution. Acetonitrile is commonly used as mobile phase 
B for RPLC separation of peptides. The freezing point of 10% acetonitrile is slightly lower 
than -9 ℃. Thus, we evaluated four different temperatures: room temperature, 4 ℃, -9 ℃, 
and -20 ℃. In order to run LC under sub-zero temperature, we used two different mobile 
phase systems: (1) Mobile phase system 1: 0.1 % formic acid in water as mobile phase A, 
and 0.1 % formic acid in acetonitrile as mobile phase B; (2) Mobile phase system 2: 0.1 % 
formic acid, 30 % methanol in water for mobile phase A, and 0.1 % formic acid in 
acetonitrile as mobile phase B. 
For mobile phase system 1, RPLC separation of E. coli digest with a gradient from 
10% mobile phase B to 35% mobile phase B was conducted at room temperature, 4 ℃, 
and -9 ℃. For mobile phase system 2, we added 30% methanol into mobile phase A ( 0.1 
% formic acid, 30 % methanol in water) to lower the freezing points to below -20 ℃. With 
this mobile phase composition, we performed RPLC separation of E. coli digest with a 
gradient from 0% B to 40% B at room temperature, 4 ℃, -9 ℃, and -20 ℃. To compare 
the separation efficiency using different mobile phases at different temperatures, a UV/Vis 
PDA detector was used. As shown in Figure 5-1, the separation performance under sub-
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zero temperatures was similar to the performance at 4 ℃ with both mobile phase systems 
1 and 2. However, as the temperature decreased, the peaks became broader. Meanwhile, 
some peptides did not bind to the column at lower temperatures, resulting in peaks eluted 
in flow through time. For mobile phase system 1 at 4 ℃ and -9 ℃, the elution profiles 
were very similar which indicates that the decrease in temperature did not affect the 
separation performance.  In general, LC separation resolution was relatively low using 
mobile phase system 2 (e.g., broader peaks). While -20 ℃ is favorable for HDX to 
minimize the back-exchange of deuterium, the RPLC separation under -20 ℃ using mobile 
phase system 2 may not provide sufficient separation resolution.  
 
Figure 5-1. UV traces of RPLC chromatograms of E. coli digest at different temperatures.  
(A) Mobile phase system 1: 89.9% HPLC water, 10% acetonitrile, and 0.1% formic acid 
as A and 99.9% acetonitrile and 0.1% formic acid as B. (B) Mobile phase system 2: 
64.9% water, 35% methanol, and 0.1% formic acid as A and 99.9% acetonitrile and 0.1% 
formic acid as B. 
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5.4.2 Back-exchange rate evaluation 
Lower temperatures are favorable to HDX separation and it has been reported that 
by decreasing the temperature from 0 ℃ to -30 ℃, deuterium exchange rate can be reduced 
the by about 40 fold [145]. However, low temperatures are not favorable for RPLC 
separation of peptides due to the lower mass transfer rate under low temperatures. Our data 
indicated that lower resolution was obtained for RPLC separation using a C18 column at -
20 ℃ than at -9 ℃. The low separation resolution resulted in insufficient separation of 
peptides and fewer peptide identifications. In complex samples, fewer peptide 
identifications decreases the overall peptide coverage and can result in the loss of 
information about binding sites.  
In order to examine the back-exchange status of deuterated peptides, fully 
deuterated E. coli digest was prepared by incubating E. coli digest with D2O for 3 days. 
The fully deuterated E. coli digest was then analyzed by LC-MS using mobile phase system 
2 at -9 ℃ and -20 ℃. The mass of each peptide eluted at different time from the fully 
deuterated sample were measured. The deuterium level of each peptide was calculated as 
follow: the average masses of the peptide detected in the fully-deuterated and non-
deuterated samples were calculated. The difference between the average masses of the 
same peptide in the fully-deuterated and non-deuterated samples was calculated to indicate 
the mass increase due to the incorporation of deuterium. Then, the mass difference was 
divided by the maximum deuterium uptake of the peptide to calculate the deuterium level 
of the peptide. The non-deuterated E. coli digest was analyzed by LC-MS/MS for peptide 
identification. An in-house developed software was used to match the deuterium labeled 
peptides to the non-deuterated peptides to identify the deuterated peptides. Briefly 
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speaking, a peptide identification list from the non-deuterated peptide sample with their 
corresponding m/z ratios was imported into the software. For each identified peptide, a list 
of m/z ratios with different deuterium uptake (i.e. +1 deuterium, +2 deuterium, +3 
deuterium, ……) was generated. The software then calculated the mass error between the 
m/z on the list and each m/z detected in the spectrum from the deuterated peptide samples 
with the similar retention time window (time tolerance can be changed). If a cluster of m/z 
values (monoisotopic distribution) of the deuterated peptide samples with mass error less 
than 15 ppm can be matched with the m/z values on the list, the deuterated peptide will be 
assigned with the sequence of the peptides identified from the non-deuterated sample. The 
mass error matching algorithm was shown in Figure 5-2.   
 




Figure 5-3. Deuteration level vs. retention time of E. coli peptides under -9 ℃ and -20 
℃. 
 
The deuteration level of each identified peptide from the E. coli digest under 
different temperature conditions was calculated to examine the deuterium back-exchange 
rate, as shown in Figure 5-3. Using mobile phase system 2 at -9 ℃ and -20 ℃, similar 
deuteration levels of identified peptides from the E. coli digest were observed, which 
indicated that the rate of deuterium back-exchange at -9 ℃ and -20 ℃ were similar. The 
back-exchange rate at higher temperature was also examined using mobile phase system 1. 
Increasing deuterium uptake was observed with the decrease in temperature from room 
temperature to -9 ℃ with the use of mobile phase system 1, Figure 5-4. When mobile 
phase system 2 was used, similar deuterium uptake was observed for the two peptides at -
9 ℃ and -20 ℃.  Considering RPLC separation at -9 ℃ offered better separation resolution, 





Figure 5-4. Mass spectra of deuterated peptides under different temperature conditions. 
 
5.4.3 Epitope mapping of Anthrax protective antigen 
After the optimization of the subzero temperature LC separation, we applied the 
platform to characterize the epitope of PA to an anti-PA antibody (C01). Differential HDX-
MS was performed, where the free PA antigen sample and the PA – anti-PA complex 
sample were analyzed using the low-temperature RPLC platform. The non-deuterated PA 
sample was analyzed using low-temperature LC for peptide identification. Then, the free 
PA and complex samples were diluted into D2O for HDX reaction. After the reaction was 
quenched, the samples were quickly digested using protease XIII and separated using low-
temperature LC for direct mass measurement. Triplicate runs were performed for each 
sample.  
The in-house developed software was used to calculate the average mass of each 
identified PA peptide after deuteration in the free PA and complex samples. The average 
mass of each peptide from the triplicate runs were then averaged and the deuteration level 
(%) was calculated by comparing the mass difference of the peptide in the free PA and 
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complex samples with its theoretical maximum deuterium uptake. Deuteration levels less 
than ± 5% were considered to not have a significant mass shift and it was concluded that 
these peptides were not involved in the binding event or the environment of these peptides 
did not change due to binding. For all the peptides with deuteration levels greater than ± 
5%, manual evaluation of the raw data was performed to ensure the validity of the 
identification. A heatmap of each identified PA peptide was generated to visualize the 
deuteration level (Figure 5-5).  
 
Figure 5-5. Heatmap of deuteration level of PA peptides obtained from differential HDX-
MS of the free PA sample and the PA – anti-PA C01 antibody complex sample. 
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From the heatmap, we observed several peptides with consistent deuteration level 
increase comparing the peptides in the free PA sample with the peptides in the complex 
sample. Thus, we concluded that the epitope of PA binding to anti-PA C01 antibody was 
AAVNPSDPLETTKPDMTLKEA. The spectra of peptides that were in this region is 
shown in Figure 5-6A. For comparison, peptides that were not affected by the binding 
event are shown in Figure 5-6B. 
 
Figure 5-6. Mass spectra of PA peptides that were (A) involved and (B) not involved in 




Figure 5-7. Heatmap of the deuteration level of PA peptides obtained from differential 
HDX-MS of the free PA sample and the PA, anti-PA antibody C01, and F01 mixture. 
 
Furthermore, the same experiments were performed for the free PA sample and a 
mixture of PA, anti-PA antibody, C01 and F01, respectively. The heatmap (Figure 5-7) 
indicates the same binding site between PA and anti-PA antibody C01 as was identified 
using when pure anti-PA antibody C01 was bound with PA. The results indicate that the 
low-temperature LC HDX-MS can be used to analyze the protein-protein interaction in a 
relatively complex sample. However, we were not able to identify the binding site between 
PA and anti-PA antibody F01 and there are two possible reasons. The binding of PA to 
C01 may be more favorable than the binding of PA to F01, so the PA may have been bound 
primarily to C01. Alternatively, PA epitope to F01 may be contain only a few amino acid 
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residues. As the mass shift for shorter peptides is smaller, back-exchange is more of an 
issue for these peptides and the differential deuterium uptake may not have been 
measurable even under low-temperature separation conditions. To address these issues, the 
low-temperature LC HDX-MS platform could be further optimized with lower temperature 
to further minimize back-exchange during LC separation and MS detection.  
5.5 Conclusions 
We have developed a low-temperature LC system to separate deuterated peptide 
samples for differential HDX-MS analysis. Using mobile phase system 1, the separation 
resolution and deuterium back-exchange effect were optimized at -9 ℃. The platform was 
then successfully applied to analyze the epitope of PA to anti-PA antibodies in both pure 
antibody sample and a mixture of two anti-PA antibodies sample. However, we were not 
able to identify the binding site of anti-PA F01 when anti-PA C01 was present. Future work 
can be done to further optimize the platform and experimental conditions to identify 
multiple binding sites. For example, capillary packed RPLC columns may be used to 
increase the separation resolution and sensitivity of the platform. Lower temperature with 
suitable mobile phase modifiers could also be applied to further minimize the back-
exchange. Modifications to the ionization process and implementation of different MS 
technology may also be considered to improve HDX identification. The back-exchange of 
peptides during the ESI process may be reduced by the incorporation of a flow of chilled 
nitrogen gas to the ESI spray. Additionally, the resolution of HDX-MS can be improved 
by using electron transfer dissociation (ETD), rather than collision induced dissociation 
(CID), which will not cause the rearrangement of deuterium on the peptides during the 
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dissociation process. Single amino acid resolution could even be achieved with the careful 
optimization of experimental conditions [149]. Overall, HDX-MS is a promising technique 
that is complementary to traditional structural biology techniques. With the incorporation 
of low-temperature LC, the level of deuterium labeling retained by peptide amides after a 
prolonged peptide separation has been improved, which will broaden the utility of HDX-
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Chapter 6 Overall summary and future directions  
6.1 Overall summary 
The work described here within this dissertation was about the developments of 
high-throughput top-down proteomics and the applications on analyzing human serum 
autoantibody repertoire.  The need for developing high-throughput top-down proteomics 
arises from the complexity of biological samples. Proteomics techniques provide the tools 
to the analysis of proteins which are essential to life. Top-down proteomics makes it 
possible to characterize and quantify intact proteoforms and provides valuable information 
to the understanding of protein functions. As current proteomics techniques can only reveal 
limited information about proteomes, the development of techniques is needed to explore 
more of proteomes.  
A two-dimensional separation platform using high-pH RPLC and low-pH RPLC 
was shown in Chapter 2 and 3, to improve the separation power of intact proteins for top-
down proteomics. The 2DLC system utilized RPLC which is the most commonly applied 
technique for intact protein separation on both of the two dimensions. By varying the pH 
conditions of the mobile phases used in the two dimensions, orthogonal separation was 
achieved for intact proteins in complex samples. The protein conformation changes under 
different pH condition due to electrostatic force changes, which alters the hydrophobicity 
of proteins. The orthogonality of RPLC separation of intact proteins under different pH 
conditions was evaluated using protein standards and the whole E. coli proteome. The 
2DLC was proved to be able to separate intact proteins efficiently and orthogonally.  
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We further developed a comprehensive online 2DLC system based on the work in 
Chapter 2 to increase the sensitivity of the top-down proteomics platform for the analysis 
of low-quantity biological samples. The two dimensions utilized Nano-flow capillary 
RPLC to minimize the usage of sample amounts. The online 2DLC system achieved 
comparable results to the offline 2DLC system with 100 times less sample injected. The 
online 2DLC system could potential provide a promising and sensitive tool for the analysis 
of low-volume samples. 
 Autoantibodies are a hallmark of many autoimmune diseases and can be present in 
serum years before clinical symptoms arise, thus the detection and characterization of 
autoantibody repertoire have been drawing attentions. 
Based on previous work in our lab, we optimized an automatic single-dimension 
RPLC platform through a custom-modified ultra-high pressure nano LC system (UPLC, 
maximum pressure 14,000 psi, operation pressure 10,000 psi) to improve the separation of 
highly homologous autoantibodies in serum. This approach has been successfully applied 
to a 12 standard monoclonal antibody Fab mixture, demonstrating the feasibility to separate 
and sequence intact antibodies with high sequence coverage and high sensitivity. We then 
applied the optimized platform to characterize serum autoantibody Fabs in a systemic lupus 
erythematosus (SLE) patient sample compared to healthy control samples, showing that 
80+ dominant antibody Fab related mass features are only observed in the SLE sample, 
which is the first top-down demonstration of a serum autoantibody pool analysis.  
The characterization of immune complexes promotes the understanding of human 
immunity and provides the information about the mechanisms of related diseases. We 
applied low-temperature LC coupled to HDX-MS to characterize the binding between 
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Anthrax protective antigen and different anti-PA antibodies. 
6.2 Future directions 
Proteins play important roles in human body, including transporting molecules, 
building cell/organism structures, catalyzing metabolic reaction, and etc. Proteomes consist 
of numerous proteins with wide dynamic ranges in term of abundance and different 
modifications. On the long way of developing top-down proteomics techniques, every step 
will need to be considered and promoted by the collaboration of researchers in different 
fields, including the separation techniques, mass spectrometry techniques and 
instrumentation, bioinformatic tools for top-down proteomics. More efficient 
multidimensional separation with higher separation power will be beneficial to the 
separation of proteomes. The development of more affordable mass spectrometers will help 
the promotion of top-down proteomics in more laboratories and boost the pace of top-down 
proteomics development. Higher resolution mass spectrometers help to study larger 
proteins with better mass accuracy. Top-down proteomics data is normally tedious to 
analyze, advanced bioinformatic tools for top-down proteomics is in urgent need to provide 
robust and accurate tools for top-down proteomics data interpretation.  
Analyzing autoantibodies in serum samples is extremely challenging due to their 
similarity and complexity. With current application of UPLC-HRMS platform described 
in chapter 4, only very limited information can be provided. The online 2DLC coupled to 
high resolution MS could be applied to analyze autoantibody repertoire, potentially 
providing deeper characterization of human serum autoantibodies. In addition, to fully 
understand the function of autoantibodies of interest, techniques that can provide structural 
102 
 
information, such as native proteomics,  hydrogen deuterium exchange mass spectrometry, 
and etc., can be developed and applied to elucidate the structures of proteins and protein 
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